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Abstract 
Breast cancer patients undergoing radiotherapy often experience severe levels of anxiety 
and depression. There is a gap in the research literature from Africa, particularly from 
Ghana, with few studies focusing on the assessment of anxiety and depression among 
breast cancer patients undergoing radiation treatment. A better understanding was 
essential to promote efforts to help breast cancer patients cope with their diagnosis and 
treatment and increase their overall quality of life. This mixed method study examined 
breast cancer patients in Ghana undergoing radiotherapy and their responses related to 
anxiety and depression through a concurrent triangulation involving an interview with 
selected professional participants and a detailed patient survey. Patients completed 2 
modified scales, the Patient Health Questionnaire and Depression Anxiety Stress Scale. 
The sample consisted of 100 patients between the ages of 20-89. Individual interviews 
were held with 6 professionals with a minimum of 5 years of work experience. Themes 
were generated through open coding of the interview data, while multiple regression was 
performed to determine the relationship between depression and anxiety with the 
independent variables . Findings of this study indicated the need intervene through 
counseling and education on behalf of patients in Ghana as they undergo breast cancer 
treatment. Age and monthly income of patients were statistically significant in predicting 
the anxiety and depression among the patients. The study’s implications will lead to 
positive change when all stakeholders take on the responsibility of implementing 
measures to promote coping strategies for breast cancer patients in Ghana.  
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Chapter 1: Introduction to the Study 
Introduction 
The interest to study anxiety and depression among cancer patients in Ghana 
started with keen observation and note-taking that I conducted over 12 years as a 
radiation therapist. The interest developed into a study and begun in 2014 with a focus on 
breast cancer. Cancer treatment in Ghana is costly, with inadequate patient’s support 
systems to cover treatment and chemotherapy drugs. These and many other multifactorial 
reasons lead to several levels of anxiety and depression prevalent amongst the patients. 
Anxiety is the feeling of fear, distress, and uneasiness of an imminent 
endangerment (Antwi, Kyei, Gawugah, Opoku, & Ogbuokiri, 2015), and in the setting of 
this study, anxiety was the central emotional distress among patients undergoing cancer 
treatment. According to Bali, (2015), anxiety has both physiological and psychological 
components. Depression is a symptom expressed through tireless sensations of 
hopelessness, unhappiness, lack of concentration, lack of energy, and insomnia, 
especially with a cancer diagnosis (Healthline, 2015). Breast cancer is the most common 
cancer among women globally according to Ward et al., (2015), and the World Health 
Organization (WHO) predicted it as the most likely reason a woman will die of cancer 
(WHO, 2007). WHO, in their 2013 global estimates, indicated that cancer of the breast 
was common in both the developing and the developed world with an estimated average 
of over 508 000 deaths every year (WHO 2013). According to studies done in Ghana by 
Wiredu & Armah, (2006) and Biritwum & Amaning, (2000), breast cancer is the 
common cause of mortality and most hospital admissions among Ghanaian women.   
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This study on anxiety and depression among breast cancer patients could 
potentially influence breast care treatment and subsequently post treatment management 
at all stages. Findings from the study could be used to modify treatment and supportive 
care protocols for the management of breast cancers in Ghana. 
Background of the Study 
Cancer of the breast happens to be one of the most impactful diseases worldwide 
and in Ghana; it accounts for the highest number of referrals at the study site. A study by 
Gukas et al., (2005) in Ghana reported that breast cancer in the indigenous Black African 
population is often severe, with unfavorable prognostic features. These functions include 
age at presentation, diagnosis with advanced stages, high-grade histological subtypes, 
large tumor size, and low rate of hormone receptor positivity (Ikeoluwapo et al., 2016). 
These features are believed to explain why most African women are more likely to die 
from the disease than women from developed countries (Ohene-Yeboah, & Adjei, 2012).  
The treatment of breast cancer has evolved over the years, offering patients high 
rates of survival (Scharl, Kühn, Papathemelis, & Salterberg, 2015). Several studies have 
demonstrated that these patients are usually at greater risk of developing psychological 
distress leading to some level of anxiety and depression (Arvidsdotter, Marklund, Kylén, 
Taft, & Ekman, 2015; Schetter & Tanner, 2012). Furthermore, this distress link among 
breast cancer patients extends to the post-treatment period with depressive and anxiety 
disorders (Vin-Raviv, Akinyemiju, Galea, & Bovbjerg, 2015). According to studies by 
Coolen, (2012) and Institute of Medicine Committee on Psychosocial Services to Cancer 
Patients/Families in a Community Setting, (2008), clients receiving treatment have fears 
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and concerns regarding mortality. Other concerns expressed by patients in the same study 
were disease recurrence, body image impairment, especially with mastectomy, alteration 
hormonal femininity treatment, and sexuality, as well as attractiveness with spouses and 
loved ones. 
Below are some selected articles involving assessment of anxiety and depression 
among breast cancer patients: 
• Husson, Mols, and Van de Poll-Franse (2011) provided information through a 
systematic review of the relation between health-related quality of life and 
information provision, depression, and anxiety among cancer survivors. 
• Hassan et al. (2015) assessed breast cancer patients undergoing treatment, 
their status and other contributing factors that lead to anxiety and depression. 
They also looked at supports and care administered to participants with a high 
risk of anxiety and depression. 
• Vahdaninia, Omidvari and Montazeri (2010) and Jacobsen and Jim (2008) 
provided different psychosocial interventions for anxiety and depression in 
adult cancer patients, in particular on the family and patients’ illness 
characteristics. They also looked at factors that predicted levels of anxiety and 
depression among breast cancer patients. 
• Research by Burgess et al. (2005) and Dauchy, Dolbeault, & Reich, (2013) 
assessed anxiety and depression among breast cancer patients using 
observational cohort studies focusing on the role of pain, the cancer type, and 
the similar treatment. 
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• So et al. (2010) examined the level of anxiety and depression and their effects 
on the quality of life of patients with breast cancer undergoing chemotherapy 
or Radiotherapy. 
• Jadoon, Munir, Shahzad, & Choudhry, (2010) used a cross-sectional study to 
assess anxiety and depression in adult cancer outpatients. 
What was missing in the literature were studies that focused on determining levels 
of depression and anxiety and how this assessment impacted treatment outcome for breast 
cancer patients undergoing radiotherapy. A more complete understanding of these issues 
resulting from this study promotes positive social change in three different ways. First, it 
serves the cancer population, especially patients undergoing breast cancer treatment, to 
help them manage depression and anxiety. Second, it enhances their efforts for coping, 
and third, it increases the overall quality of life of these patients undergoing treatment.  
This research has brought to light the significance of the level and the need to 
assess breast cancer patients regularly while they undergo their treatment regime. This 
study also addressed diagnosis and treatment of breast cancer and the overall workload of 
the staff attending to patients undergoing treatment. 
Problem Statement 
Studies conducted by Watts, Prescott, Mason, McLeod, and Lewith (2015) and 
Birnie, Garland, and Carlson (2009) have established that every cancer patient in their 
cancer journey will at some point experience some degree of anxiety and depression. The 
authors further indicated that this experience progresses during their treatment duration 
and post treatment. The authors suggested that families do suffer from the effects of 
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anxiety and depression in patients undergoing treatment. A phase of emotional shock and 
disbelief is common as part of the patient’s psychological characteristics after a diagnosis 
is made, followed by anxiety (Birnie et al., 2009). 
According to Hassan et al. (2015), breast cancer is one of the most feared diseases 
among women, and it could induce some level of changes of psychological disorders 
such as anxiety and depression. According to a study by Kyei, Arthur, Vanderpuye, & 
Antwi, (2008), the majority of breast cancer patients undergoing treatment at the study 
site were not comfortable and satisfied with the trends of the radiation treatment they 
received. This unsatisfactory nature was evidenced by the degree of complaints leading to 
an intensification in their levels of anxiety and triggering many levels of depression 
(Jadoon et al., 2010). 
Among the study population, anxiety and depression are the most dominant 
symptoms that are usually under predicted and undertreated from observations. 
According to Joffe et al., (2012), depression and anxiety reduce the lifespan of patients 
and affect their overall quality of life. Anxiety is common in patients with advanced 
disease and associated with physical disability, augmented health difficulties, as well as 
poor quality of life (Lenze & Wetherell, 2011). Depression, on the other hand, leads to 
increased mortality, affects the total well-being of clients, and disturbs the daily 
functioning of patients undergoing treatment (Martín-María et al., 2016).  
Several studies including Hassan et al. (2015), Dauchy et al. (2013), and So et al., 
(2010) have been conducted in the developed world on anxiety and depression. This 
research has led to a good understanding of some key features associated with anxiety 
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and depression, though there is a gap in literature with Africa, particularly for Ghana. 
Among all the research studies identified, only a few have focused on the assessment of 
anxiety and depression among breast cancer patients undergoing radiation treatment 
(Srivastava et al., 2016; Hassan et al., 2015; Chintamani et al., 2011; Dastan & Buzlu, 
2010; Vahdaninia et al., 2010). These studies were mostly in India, Iran, Malaysia, 
Turkey, and the United Kingdom. None of these studies have been done in Ghana, West 
Africa, or even Africa at large to assess the level of anxiety and depression among breast 
cancer patients undergoing Radiotherapy. 
Purpose of the Study 
With this study I aimed to find various interventions for depression and anxiety 
among breast cancer patients in Ghana. I used a mixed method design to gather both 
quantitative and qualitative data. The qualitative data were from interviews with selected 
working participants while the quantitative data came from a non probabilistic approach 
using a structured questionnaire to assess the severity and frequency of anxiety and 
depression as well as the therapy and the quality of life experienced by patients 
undergoing breast cancer treatment in Ghana. 
Research Questions and Hypothesis 
The research questions for this study were; 
RQ1-Qualitative: What are the experiences of breast cancer patients undergoing 
radiotherapy with high-level anxiety and depression?  
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RQ2-Quantitative: How does the effect of breast cancer stage, the cost of 
treatment, and waiting time affect a patient’s level of anxiety, depression, and 
treatment responses?  
H0: There is no significant relationship between the responses of breast cancer 
patients on their treatment and their level of anxiety and depression and 
treatment response. 
H1: There is a significant relationship between the responses of breast cancer 
patients on their treatment and their level of anxiety and depression and 
treatment response. 
Theoretical Framework 
The application of the health action process approach (HAPA) theory is essential 
in this breast cancer assessment, and it is in the group of the behavioral theories 
(Schwarzer, 2008). This theory is a psychological theory of health behavior change 
developed by R. Schwarzer in 2008. The model was used to describe, predict, and explain 
breast cancer treatment processes that lead to anxiety and depression. It was also used to 
examine psychological concepts that mutually target and clarify what influences patients’ 
depression and anxiety during the treatment journey. The theory provided frameworks 
that inform preventive action during the treatment trajectory. The study comprises three 
stages: 
1. the informed decision-making stage, through the help of the patients and 
caregivers or family members;  
2. the treatment stage; and  
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3. The post treatment phase. 
Nature of the Study 
I used a mixed method design to gather both quantitative and qualitative data. The 
interviews that were qualitative in this research were with some selected staff who 
worked in close collaboration with patients (doctors, nurses, radiation therapists). The 
quantitative data was a representative survey with questionnaire using a sample of 100 
and with a non probabilistic approach because there was no appointment system for 
patients undergoing treatment for the assessment. The selection of patients took place as 
and when patients enrolled in the treatment after they signed indicating consent. A 
collection of data for the study was done using a semi structured questionnaire that was a 
modified version of Patient Health Questionnaire and the Depression Anxiety Stress 
Scales. Patient demographics such as the age, sex, education, marital status, and income 
level were measured. The period of treatment, waiting times, type of cancer, and the 
remedy for the anxiety and depression experienced were measured as well. 
Assumptions 
In this study, the assumption was that the selection of participants who 
volunteered to participate in the study was not biased. Another assumption was that the 
participants (patients) responded to the questionnaire honestly, and the members of the 
working team (professionals) reacted to the interview fairly. An additional assumption 
was that I did not influence the responses of the participants on the items administered. 
Finally, I assumed the sample to be representative of the entire population.  
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Scope and Delimitations 
The extent of the study involved the assessment of anxiety and depression during 
their treatment trajectory as the independent variable and the relationship between the 
responses of breast cancer patients as dependent variables. Also, there was a careful 
examination of the anxiety and depression and how these affected the overall treatment 
outcome. Through this study I assessed the relationships as listed in the research 
questions and hypotheses. I used a convenient sampling of patients undergoing breast 
cancer treatment in Ghana, and the population consisted of all breast cancer patients 
referred to the Oncology Department of the Korle-Bu teaching hospital. There have been 
few theories that relate to the problem statement; however, the only one that could relate 
primarily to the core was the HAPA.  
Limitations 
A limitation of a study is the standard structures within the designs of the 
methodology that set boundaries on the clarification of the results (Labaree, 2009). The 
limitations of this study stemmed from three levels of issues. The first was the 
recruitment of patient participants for the quantitative study. The plan was to select 
patients before the start of radiation therapy. However, this limited the selection because 
not every patient ended up being treated. In some instances, the cost of treatment alone 
prevented patients from undergoing treatment; other occurrences included the death of 
patients awaiting treatment and other multifactorial reasons. I planned to begin 
recruitment directly from participants who had begun their treatment.  
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The second limitation was the language barrier because not all the patients spoke, 
read, or wrote in English. The plan was to help in translation into the local languages 
where the need arose. I translated the questionnaire into the local language during the 
data collection, and that assisted the whole process. Also, I excluded non-Ghanaians from 
the study. 
The third and final limitation was the fact that some patients did not respond 
honestly to the survey questions for fear that the staff may wrongly interpret it. I 
continuously assured patients to gain the firmest of confidence in their responses to the 
questions. 
Significance of the Study 
Through the assessment of anxiety and depression among breast cancer patients 
undergoing radiotherapy in Ghana, the study could offer oncology care teams (radiation 
oncologists, radiation therapists, and oncology nurses) an understanding of the common 
elements of anxiety and depression. Through the management of anxiety and depression, 
the quality of life of breast cancer patients undergoing radiotherapy could improve, 
particularly during their end-of-life stage. The expectation was that the study would 
promote positive social change in the form of coping strategies and greater awareness of 
the conditions of breast cancer with the aim of preventing it. The latter would occur 
through various levels of cancer education to both the client and the caregivers. With the 
coping strategies, patients undergoing treatment could benefit from daily tips on breast 
cancer management from the oncology nurses.  
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The contribution of the various coping mechanisms resulting from the survey 
through the feedback of the patients undergoing treatments and the interactions with the 
working staff could help alleviate these emotional symptoms and ensure the total well-
being of the patients. The study examined factors that were critical and impacted patients’ 
overall treatment performance, future implications, and overall social life. Findings from 
the study could also be used to plan policies that could support methods beneficial to the 
advancement of oncological services in Ghana and Africa since many neighboring 
countries in the West Africa patronize the oncology services in Ghana. The expectation 
was that the study would inform family members and caregivers to make conscious 
decisions on managing a patient during treatment and post treatment stages. Finally, the 
possible positive social change resulting from the study could be seen globally and 
locally by providing a basis for future research, especially regarding cancer and 
depression and anxiety. 
Summary 
In the next chapter I review the literature of the various components of the study 
centering on the main areas such as search criteria, the gap in the literature, the social 
implication of the survey, and the HAPA theory and its influence on and alignment with 
the study. I also look at breast cancer in Ghana and the need for awareness for early 
presentation. Finally, I focus on the anxiety and depression, causes, symptoms, 
prevalence, interventions, and the validity of the scales for the study. 
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Chapter 2: Literature Review 
Introduction 
According to a study by Kyei, Arthur, Vanderpuye, & Antwi, (2008), the majority 
of breast cancer patients undergoing treatment at the study site were dissatisfied with the 
radiation treatment they received. This unsatisfactory nature was evidenced by the 
various degrees of complaints leading to an intensification in the patients’ levels of 
anxiety and triggering many levels of depression (Jadoon et al., 2010). This study 
elucidated the various interventions required to minimize depression and anxiety among 
breast cancer patients undergoing radiation therapy in Ghana.  
In this chapter I review current literature in the field of public health and social 
science. The search criteria covered areas such as breast cancers, a population in Ghana 
with cancer of the breast, and those undergoing radiotherapy at the oncology unit at the 
study site. The search further considered the Ghanaian culture and the level of 
occurrences of breast cancer among the Ghanaian population. The review covers the 
theory of the HAPA that I used as a framework for this study. This includes a review of 
HAPA and its influence on the study as well as its alignment with the study. Also, there 
is a thorough discussion of the risk factors of breast cancers and the associated levels of 
anxiety and depression. The review also covers the causes, prevalence, symptoms, 
assessment, disorders, and measures of depression and anxiety among breast cancer 
patients. Finally, the literature search looked for information on ways to manage breast 
cancer patients undergoing radiotherapy who presented with a high level of anxiety and 
depression. 
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Search Criteria/Description of Literature Search 
A literature search conducted covered all areas of anxiety and depression. I 
performed the search using various search engines such as Google Scholar, Academic 
Search Premier, Medline, Psych Articles, EBSCOhost, PsycINFO, MEDLINE, PubMed, 
Academic Search Complete, CINAHL Plus with Full Text, Cochrane Database of 
Systematic Reviews, ProQuest, and SocINDEX. A thorough examination took place on 
several physiological variables in breast cancer progression such as anxiety, depression 
that extends to anger, blame, coping, helplessness, hopelessness, faith, hope, humor, and 
optimism, among others. Several different sources such as Hofmann, Sawyer, Witt & Oh, 
(2010), Satin, Linden & Phillips, (2009), and van’t Spijker, Trijsburg & Duivenvoorden, 
(1996) were also helpful. 
Furthermore, I reviewed a broader search through the reference lists of all 
relevant studies carried out on the assessment of anxiety and depression among cancer 
patients. I expected that the search would uncover all review articles and all materials 
linked to this topic for additional review.  
Gap in the Literature 
Although several studies from the developed world have a good understanding of 
some key features associated with anxiety and depression (e.g., Hassan et al., 2015; 
Dauchy et al., 2013; So et al., 2010), there was a gap in the literature from Africa, 
particularly for Ghana. Only a few studies had focused on the assessment of anxiety and 
depression among breast cancer patients undergoing radiation treatment (Chintamani et 
al., 2011; Dastan, & Buzlu, 2010; Hassan et al., 2015; Srivastava et al., 2016; Vahdaninia 
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et al., 2010). These studies were from the India, Iran, Malaysia, Turkey, and the United 
Kingdom. There had been no studies done in Ghana, West Africa, or even Africa at large 
to assess the level of anxiety and depression among breast cancer patients undergoing 
radiotherapy. 
What was missing in the literature were studies that focused on assessing levels of 
depression and anxiety and how this assessment impacted treatment outcomes for breast 
cancer patients undergoing radiotherapy. Coming to a better understanding through this 
study could promote positive social change in three different ways. First, it would serve 
the cancer population, especially patients undergoing treatment, to manage depression 
and anxiety. Second, it would enhance efforts for coping, and third, it could increase the 
overall quality of life of these patients. 
Social Implications of the Study 
Depression and anxiety have significant roles in the coping mechanisms for 
patients undergoing radiotherapy. Almost all patients at some point in their treatment 
trajectory experience some level of anxiety and depression, but the severity and 
management of this play a key factor in the survival of the patients. Issues with cancer 
management have implications and side effects depending on the stage of disease. 
Coupled with depression and anxiety could, for a variety of reasons, play a key factor in 
patient mortality. This study could help improve the overall quality of life among 
patients, their total well-being, their psychosocial functioning, and the overall patient 
satisfaction with their treatment.  
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As a result, several issues that arise from anxiety and depression with breast 
cancer patients could decrease significantly. As described by Hofmann et al. (2010), 
mindfulness that leads to a mental state without worry about the present experience could 
be used as a therapy for patients undergoing breast cancer treatment. The results of that 
study suggested that working on the minds of patients improves symptoms of anxiety and 
depression (Hofmann et al., 2010). Hence, this assessment could be a memory-based 
therapy for patients, and this could improve the social relevance of the study. The 
significance of the survey could be the contribution of the various coping mechanisms 
that will result in the review through the feedback of the patients undergoing treatments 
and the interactions with the working staff. This could be important for the patients 
undergoing treatment and any other patients referred to the oncology unit. It could also be 
important for the working team who are in the position of ensuring the total well-being of 
the patients. The study could help to re-examine factors that impact patients’ overall 
treatment performance, future well-being, and social lives.  
The study could potentially foster new policies in the three oncology units of 
Ghana and the overall management of the treatment of cancer in the nation and beyond. It 
may also inform the multidisciplinary team involved in the management of breast cancer 
about the late presentation of breast cancer in Ghana. The implications for positive social 
change could also include decreased depression and anxiety for late presenting breast 
cancer patients as well as the effective management mechanisms for their caregivers. It 
could also help project knowledge useful for the prevention of breast cancer. 
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For this study, I explained the intervention required for depression and anxiety to 
participants. Therefore, they could gain the courage to handle issues such as depression, 
and that could help them to deal with a lack of outside support. All these could be 
possible when patients are rightly informed about their conditions, stages, and the 
possible treatment outcomes.  
Theoretical Framework 
Theories 
In this study, I reviewed various models of health behavior change that provided 
an outline of features that affected the entire study. In the study I examined one of the 
components of the behavioral change theories, the HAPA. Behavioral change theories 
usually try to describe why behaviors change and the environments conducive to change 
(van der Linden, 2013). Several scholars have lately presented differences between the 
theories of change and the models of behavior (van der Linden, 2013). However, these 
changes of principles are more practice-oriented and usually aimed at changing a given 
behavior, whereas the models of behavior are more analytical and typically trend towards 
understanding the psychological factors that explicate or envisage an exact response 
(Chatterjee & Das, 2015).  
Health Action Process Approach 
HAPA is a psychosomatic change theory of health behavior developed by R. 
Schwarzer in 2008. The HAPA postulates at least two distinct stages, a motivation or pre-
intentional phase and a volition or self-regulatory or action phase. In the motivation 
phase, three variables are held to influence intention directly, the risk perception or the 
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risk awareness, the outcome expectancies, and the self-efficacy (Schwarzer, 2004). The 
volition phase is further divided into three stages, the planning phase, the initiation phase, 
and the maintenance phase (Figure 1). 
 
 
Figure 1: The HAPA, adapted from Schwarzer, 2004 
 
Influence of the Health Action Process Approach on the Study 
The HAPA was used to predict, describe, and explain breast cancer treatment 
processes that lead to anxiety and depression. HAPA is a clear outline of several 
motivational and volitional concepts used in the explanation and the prediction of 
individual changes in health behaviors among breast cancer management. When applying 
the HAPA model to breast cancer management, one of the preeminent predictors of 
intention that represents the true nature of the conditions of the clients is self-value. 
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However, planning has also been proven to be a primary predictor of the actual behavior 
(Luszczynska & Schwarzer, 2003).  
For the motivational phase of this study, the issues arising were the growing risk 
awareness for patients undergoing treatment, and their level of outcome expectancies as 
described extensively in the study of Schwarzer et al., (2003). In this phase, also, there 
was a level of concern usually seen as a threat to the patients on their level of survival 
and coping with the treatment. These threats may be due to the unestablished 
expectancies and news about other patients who have undergone treatment. The patient's 
beliefs also characterize this phase of the treatment and the known alternative or 
traditional treatment. This period ends with a formation of a clear behavioral intention 
towards the treatment received that will result in survival (Schwarzer et al., 2003). In the 
volitional stage, once there was an intention to change a health behavior, such change 
must be planned, introduced, and sustained (Schwarzer, 2008). Plans were made to 
accommodate and manage some level of relapses which may occur during the study.  
Alignment of the Health Action Process Approach With the Study 
I used the theory to describe, predict, and explain breast cancer treatment 
processes that lead to anxiety and depression. I also used it to examine a series of 
psychological concepts that also clarify what encourages patients to feel depressed and to 
be anxious at some point in the treatment journey. Finally, I used the theory to look at 
frameworks that informed patients how to take preventive action at some point in their 
treatment trajectory. In doing these, the study involved three stages: 
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1. the informed decision-making stage, through the help of the patients and 
caregivers or family members;  
2. the treatment stage; and  
3. The post treatment phase. 
Breast Cancer in Ghana 
Breast cancer treatment follows a treatment depending on the stage and the type 
of disease. It is usually a multidisciplinary approach comprising Surgery, Radiotherapy, 
Chemotherapy, and Hormonal therapy. The specialists provide the opportunity of 
multidisciplinary diagnosis and treatment for patients. The experienced team in one’s 
field delivers this service with the devices of technology. Apart from these, there are 
other supportive services like disease management of breast cancer, nutrition and genetic 
counseling, psychosocial support programs, and physical therapy (WHO, 2017). For 
Surgery, there is a Mammoplasty, Tissue expansion, Lymph node dissection, 
Lumpectomy, and Mastectomy. Mammoplasty has to do with plastic surgery to increase 
or reduce the size of the breasts or to reconstruct a breast.  
Tissue expansion is the process of inserting a balloon under the skin and then 
gradually expanding it to stretch and grow the skin and surrounding tissue. Lymph node 
dissection is simply the surgical removal of a lymph node. Lumpectomy is the surgical 
removal of a lump (tumor) in the breast. Finally, mastectomy is the surgical removal of 
some or all of the breast. The medical procedure is the Radiation Therapy which is the 
use of high-energy beams to destroy cancer cells and shrink tumors. Chemotherapy is 
basically through medications to kill cancer cells. The latter and Radiation therapy 
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usually take place at the Oncology Department and the study will focus on patients 
undergoing radiation treatment, irrespective of whether they have had surgery or 
chemotherapy. 
The Oncology Department of Accra, Ghana, is the Nation’s referral center for all 
malignant disease in Ghana. It also serves as a cancer center for several neighboring West 
African countries such as Togo, Benin, Cote d’Ivoire, Senegal, Burkina Faso, Guinea, 
among others. It is one of the three Oncology departments within the country, serving the 
southern Ghana and other foreigners referred. The other two are the Oncology 
Department of Kumasi and the Swedish Ghana Medical which is a Private firm between 
the Ghana Government and the Swedish Government. 
The breast cancer population from the year 2012, 2013, 2014 and 2015 received 
from the cancer registry at the Oncology Department in Accra were 479, 456, 431, and 
513 respectively. Out of these population, the patients who ended up having their 
radiation treatment aside surgery, chemotherapy, and hormonal therapy, were 307, 280, 
257 and 349 within 2012, 2013, 2014 and 2015 respective years.  
Patients Flow and Staff 
The department has in all five units that will serve the entire breast cancer 
population. There is the Clinic, which will be the first point of call for the patients when 
referred and where Oncologists will decide whether the related case will require 
radiotherapy or not. The second will be a pre-planning decision called the Simulation 
before radiotherapy. The third will be the Planning unit which will see to the treatment 
preparation of the breast cases and the prescription of the doses for treatment. The fourth 
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stage will be the Mold room where the field of the treatment will be defined and finally 
the treatment stage where the actual dose will be delivered to the breast as prescribed. 
The working staff will be the Oncologists, Radiotherapists, the Medical 
Physicists, and the Oncological Nurses. These will together manage, plan, treat, and 
review patients that will be undergoing breast cancer treatment. 
Culture Against Breast Cancer  
According to the Africa Watch magazine in 2015, breast cancer is associated with 
high mortality in many women in sub-Saharan Africa, though treatment is available 
within the continent (Debrah, 2015). WHO (2015) revealed a total of 2,000 Ghanaian 
women diagnosed with breast cancer in 2012, and 50% of these cases died. With early 
breast cancer, curative treatment is possible, and the author quoted the 2014 recipient of 
the Trust Women Journalist Award and the winner of the 2015 African Story Challenge, 
Chika Oduah; ‘Many African languages do not have a word for the cancer disease.’ In all 
research studies conducted within West Africa by several researchers, approximately six 
out of eight women will die from the various level of late breast presentation  
(Ikeoluwapo, Adetola, Adenike, et al., 2016; Ohene-Yeboah, & Adjei, 2012; Gakwaya, 
Kigula-Mugambe, Kavuma, et al., 2008). However, the reverse occurred in the developed 
countries where approximately six out of eight women were likely to survive breast 
cancer after treatment (Assi et al., 2013; Ferlay et al., 2010).  
The Africa Watch reports that most of the African women seek help and support 
from alternative healers such as priests, herbalists or spiritual healers even before they 
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think about the hospital, which in the end precariously delays and prolongs their disease 
(Tammemagi, 2007).   
Contributing Factors to Breast Cancer and Their Impact on the Study 
Being a woman is one of the primary risk factors for developing breast cancer. 
Though men can develop breast cancer (1/100), the disease is more common among 
women than men according to the American Cancer Society (ACS), (2013). Also, 1/8 of 
all invasive breast cancers are in women younger than 45 years, and 2/3 of all invasive 
breast cancers are in women over 55 years (ACS, 2013). According to Allicock, Graves, 
Gray, & Troester, (2013) and Clegg-Lamptey & Hodasi, (2007) possible reasons are 
explaining why most African women are more likely to die from breast cancer compared 
to women from other middle and high-income countries. These factors include a 
presentation at a young age, diagnosis with advanced stage, large tumor size, high-grade 
histological sub-types and low rates hormonal receptor positivity (Ohene-Yeboah & 
Adjei, 2012).  
A study conducted by Ohene-Yeboah & Adjei, (2012) indicated that there had 
been several differing views of a stage of presentation in Ghana, the lack of awareness 
and the availability of screening schemes which in the end contribute to the overall 
survival of the patients. From studies reported by ACS, (2013) 5-10% of all breast cancer 
cases are believed to be hereditary, resulting from genetic defects called mutations, 
inherited from a parent. Several other studies have reported the low levels of education as 
well as lower socioeconomic status associated with a delayed presentation of breast 
cancer (Ohene-Yeboah & Adjei, 2012; Elgaili, Abuiris, Rahman, et al., 2010). This low 
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education resulted in low levels of knowledge, causes, and complications of breast cancer 
within Africa and Ghana (Briggs et al., 2010).  
These concerns in Ghana, from the social point of view, keep compounding 
especially with only two public radiotherapy centers and one private. There is also the 
lack of a national breast cancer screening program, which echoes the frail health care 
system in Ghana as well as the poor access to health facilities reported by Ohene-Yeboah 
& Adjei, (2012). There are also constraints in resources within the Oncology setting 
regarding staffing, equipment, and spacing. Again, the cost of breast cancer care is high 
in Ghana because the National Health Insurance does not cover the total cost of therapy 
and patients are required to make payments for their treatments (Opoku, Benwell, & 
Yarney, 2012).  
All these factors suggest a critical implication of the study in one way or the 
other. First, women in the African perspective specifically in Ghana are seen as the 
weaker vessel within the family, and therefore, a combination of the effect of a diagnosis 
of breast cancer could cause them into some level of anxiety and depression. Also, many 
of the women presenting breast cancer in Ghana are illiterate, and that puts more burden 
on them regarding the coping strategies needed for the management of breast cancer. 
Finally, the cost of treatment is a major blow to patients, because the ordinary Ghanaian 
will have to pay the treatment themselves. Payment of complete cancer treatment could 
take on their whole life savings, especially when they have a minimal or no support or 
help from any family member, organizations, or even political, corporate bodies. 
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Cost of Breast Cancer in Ghana  
Breast cancer treatment and its related cost are financially straining for patients 
and their caregivers in Ghana. Referrals are delayed unnecessarily due to patient’s 
noncompliance and cost of treatment amongst other things. Although efforts to enroll 
breast cancer diagnosis, treatment, and management to the Ghana’s National Health 
Insurance Scheme (NHIS) has not been entirely successful, part of Surgery has been 
absorbed (Hughes, Amoah, Ahiabor, & Awuah, 2012). Data from NHIS, (2010) indicates 
that only 34% of the population of Ghanaian, had an active membership and that shows 
that only 34% of cancer patients can access the scheme for Surgery. For Radiotherapy, 
Chemotherapy, and hormonal therapy, the patients bear most of the cost, and these are 
very expensive. This cost of treatment is, dependent on the stage of the disease according 
to Warren, Yabroff, Meekins, Topor, Lamont, & Brown, (2008) and the cost of care 
continuum is a scary factor. Advanced stages have increased cost compared to a lesser 
value for early stages and early diagnosis (Ginsberg, Lauer, Zelle, Baeten, & Baltussen, 
2012). 
Currently, the authorities base the cost of Radiotherapy for breast cancers on the 
stage and the intent of the disease. The average treatment cost of breast cancer treatment 
at the study site in Accra, Ghana is between the ranges of $ 1,000 - $2,000. 
Chemotherapy, on the other hand, ranges from $1000-$7,000 for multi-agent protocols. 
Given the limited resources in Ghana and the fact that the average Ghanaian does not 
earn that much income, there is the need for interventions for funding. Zelle, Nyarko, 
Bosu, et al., (2012) identified that cost-effectiveness analysis which relates to the effects 
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of interventions in health and cost of treatment, could help guide decision makers in 
breast cancer management in Ghana. 
The deliberations of the cost of breast cancer in Ghana and its impact on patients 
undergoing radiation treatment at the study site will be incomplete without the 
consideration of the impact of such burden on the economic barriers of the average 
Ghanaian woman seeking for screening and treatment (Opoku, Benwell, & Yarney, 
2012). In the study by Opoku et al., (2012) patients expressed their displeasure on the 
high cost of radiation treatment and the encumbrance it places on themselves, families 
and their overall lifetime savings. The authors indicated that such burden could 
significantly affect the overall treatment outcome for patients. 
There is currently no comprehensive and systematic cancer control policy for 
breast cancer treatment in Ghana (Zelle, et al., 2012). There is also very low cost-
effectiveness of cancer control in Ghana or any other low-income country (Zelle & 
Baltussen, 2013). The treatment of breast cancer guidelines is virtually vague, and 
radiotherapy is available in only two largest cities in Ghana, generating essential barriers 
regarding geographical access. The development of a National Cancer Registry is also at 
the primary stage according to Vanderpuye, (2012) resulting in difficulties in the accurate 
estimation of the national cancer burden in Ghana. Vanderpuye further reiterated that a 
comprehensive information on the distribution of diseases at the regional levels would 
help to ensure adequate resource use, appropriate access and the provision of care to all 
Ghanaians (Vanderpuye, 2012).   
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Globally, the literature on the cost of breast cancer treatment emphases is largely 
in high-income countries (Ginsberg, Lauer, Zelle, Baeten, & Baltussen, 2012). As a 
result, extrapolation of the cost to the low-income countries becomes difficult due to the 
several variations in context. A typical example is the breast screening programs, wherein 
the advanced environments, different age groups and target tool programs are used 
differently from what happens in the developing settings (Anderson, Cazap, Saghir et al., 
2011). Table 1 shows some of the interventions for breast cancer control currently 
ongoing in Ghana. 
Anxiety and Depression as Risk Factors for Breast Cancer 
Risk factors for breast cancers increase the incidence of the populace developing 
breast cancer. Several risks factors such as family history, age, and medical history are 
beyond the control of clients. The monitoring of other factors such as the weight of the 
participants and alcohol consumption is also possible. The plan will be to conduct 
literature searches with anxiety and depression as a risk factor for breast cancer. 
Jacques (1998) identified that women with depressed mood due to an increased 
rate of black bile were likely to develop breast cancer and this result supported an 
association between the occurrences of breast cancer and some psychosocial factors 
(Hong & Tian, 2014). Other studies have also examined the risk of breast cancer and 
some stressful life events that could result in anxiety and depression (Yang et al., 2017; 
Metcalfe et al., 2013). In another study, there was an evaluation of the risk of breast 
cancer with some criteria for stressful life (Lin et al., 2013). The death of a spouse, death 
of a relative or close friend, health crisis, marital difficulties, financial crisis, and their 
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risk of developing breast cancer were identified as associated factors (Lin et al., 2013). At 
the end of the study, there were reports on two indicators. The first was that there was no 
evidence between a stressful life and breast cancer development and second was no 
indication of stressful life and the increased risk of recurrence (Lin et al., 2013). 
 
Table 1 
Various Individual Interventions for Breast Cancer Control in Ghana According to the 
Stages at Presentations by Zelle et al. (2012). 
 
Stage  Treatment Down-staging 
interventions 
Palliative care 
Stage I & II 1. Lumpectomy with 
axillary dissection  
2. Radiotherapy 
3. Systemic therapy  
-Creating the Awareness  
-Education on breast self-
examination  
Supportive care 
Pain 
management  
Psychosocial 
care 
Stage III 
 
1. Modified Mastectomy   
2. Adjuvant Chemotherapy 
3. Radiotherapy 
4. Hormonal therapy and 
possibly more 
chemotherapy 
-Biennial clinical breast 
examination for women 
aged 40–69 years 
- Active community 
outreach screening 
 
 
Stage IV 
 
1. Palliative systemic 
therapy   
2. Palliative radiotherapy  
3. End of life 
hospitalization 
4. Total mastectomy for 
eligible patients and 
hormonal therapy 
 -Palliative Care 
-Volunteers training 
program  
-Home-based visits every 
fortnight  
-Pain treatment with 
morphine, laxatives 
-Palliative Radiotherapy for 
eligible patients.  
 
Diagnosis of Anxiety and Depression Among Breast Cancer 
The incidence of anxiety and depression among breast cancer patients appears to 
be reliant on several factors including the severity of the disease, performance status, 
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patient’s disability level, and patient’s history (Sogaard, Thomsen, Bossen, Sorensen, & 
Norgaard, 2013; Aapro & Cull, 1999). Somerset et al., (2004) on the other hand were of 
the view that those significant symptoms of anxiety and depression are underestimated 
and undertreated in women with breast cancer. One of the explanations given by 
Greenberg (2004) was that women with breast cancer were hesitant to reveal their 
emotional concerns. Chou, Kuang, Lee, et al., (2016) also indicated that cancer care 
teams are mostly not familiar with such symptoms screening. The suggested diagnostic 
features that could be for anxiety and depression among breast cancer patients according 
to Mura, Bhat, Pisano, et al., (2012) are; history of psychiatric ailment, pain, lack of close 
relatives, race, ethnicity, and personality. 
Anxiety and Depression Among Breast Cancer Patients 
Breast cancer according to Hassan, et al., (2015) is one of the most feared 
diseases among women, and it could induce some level of changes of psychological 
disorders such as anxiety and depression.  
Causes of Anxiety and Depression Among Breast Cancer Patients 
There are several reasons for of the depression and anxiety experienced amongst 
breast cancer patients undergoing treatment. Identified causes could be physical, 
psychological, emotional, environmental, social and spiritual as indicated by the National 
Institute of Mental Health, (2014). Possible physical causes that affect breast cancer 
patients during treatment could be the waiting time, the cost of therapy, and nutritional 
problems such as loss of appetite. For psychological causes, there are nervousness, 
touchiness, issues with sleep, and level concentration (National Institute of Mental 
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Health, 2014). Other emotional reasons could be single status and breakups in marriages 
as a result of the disease (CDC, 2012). Other social factors could be the staff-patients’ 
relationship, and Spiritual factors such as the fear of treatment, death, and the unknown 
(CDC, 2012). With breast cancer, though the causes of anxiety and depression are most 
times not the same, they usually occur at the same time. 
Prevalence of Anxiety and Depression in Breast Cancer Patients 
According to Baqutayan, (2012) anxiety is one of the leading psychological 
challenges associated with cancer. In effect, every cancer patients undergo a level of 
anxiety at some point in their disease trajectory. This level of concern, however, increases 
as patients identify how severe their breast condition is with the stage of presentation and 
how the treatment progresses. It is also essential to note that levels of anxiety differ from 
patients to patients, and stages to stages and therefore management will be different from 
every patient undergoing treatment. Depression, on the other hand, is a standard clinical 
unit with a lifetime risk and the most common psychiatric problem faced by breast cancer 
patients (Holland, 2010). The diagnosis of breast cancer is itself a marked stressor, and 
therefore patients tend to get an added psychosocial and biological stressor that 
accompany cancer and further raises the likelihood of becoming depressed.   
Breast cancer patients usually may experience anxiety and depression at different 
stages of the cancer treatment while undergoing radiotherapy and antedating a recurrence 
of their breast cancer. This experience may result in their feelings of pain, disturb their 
sleeping patterns, causes vomiting and nausea and affect their overall quality of life.  
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Symptoms of Anxiety and Depression in Breast Cancer Patients 
The expression of the symptoms of anxiety and depression among breast cancer 
patients undergoing radiotherapy may be masked. Usually, breast cancer patients 
undergoing treatment experience persistent sadness, changes in their mood feelings of 
pessimism, and the sense of hopelessness (Steiner, Wagner, Bigatti, & Storniolo, 2014). 
Others have a sense of guilt, helplessness, and worthlessness. There is also sometimes the 
loss of interest or the loss of pleasure in the usual activities (Anxiety and Depression 
Association of America (ADAA), 2016). Others also experience levels of fatigue, 
decreased energy level and a feeling of some degree of slowness in life. At some point in 
time, there is a difficulty in remembering events, concentrating on matters, and decisions 
making. There is also the decrease in appetite, loss of weight, overeating, and overweight. 
Other times, there is insomnia, oversleeping, restlessness, and irritability (ADAA, 2016). 
In extreme cases, there are thoughts of death or suicide, and suicidal attempts by the 
patients (ADAA, 2016).  
Interventions and Treatment of Anxiety and Depression 
Psychological. There is a considerable influence on the consequences of anxiety 
and depression in patients undergoing treatment, and this effect decrease patient’s ability 
to live independently (Rozzini, Chilovi, Peli, et al., 2009). There is also an upsurge of the 
high risk of depression and anxiety among breast cancer patients on the advancement of 
Alzheimer's disease (Lu, Edland, Teng, et al., 2009). Azermai, Petrovic, Elseviers, et al., 
(2012) recommended in their study that the treatment of the symptoms of depression and 
anxiety should be a critical component of the overall treatment of Alzheimer's disease, as 
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part of interventions to management. One of the studies reviewed found that the extent of 
illness and physical impairment from treatment undergoing breast cancer treatment could 
predict the mood disturbance of patients (Bagheri & Mazaheri, 2015). The results also 
indicated that general satisfaction and quality of life also influence the overall 
psychological interventions.  
Moreover, issues with the degree of sexual indisposition have a psychological 
impact on breast cancer patients undergoing treatments and this can be disturbing. In a 
study by Ives, Saunders, Bulsara & Semmens, (2007) women who survived breast cancer 
after treatment and later conceived were 37% (45/174) compared to the population 
reviewed. In their conclusion, the authors concluded that the treatment of breast cancer 
has a negative impact on procreative opportunities for women of childbearing age. 
Additionally, there is the psychological effect on the family and extended members of 
patients as a result of the treatment. These effect changes in the identity of the family, 
daily functioning and the extent to the roles they play. A study by Woźniak & Iżycki, 
(2014) documented that spouses of patients undergoing treatment were as distressed as 
cancer patients. The study concluded that there is a correlation between distressed 
patients and their partners.  
Cognitive-behavioral therapy (CBT), is one of the many interventions for 
managing depression and anxiety. According to ADAA, (2016) CBT can teach 
participants undergoing treatment, ways to manage their fears and other symptoms they 
expressed as a result of their level of anxiety and depression. According to ADAA (2016) 
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could be done by finding the problem and taking control of their emotions. This therapy 
will also involve the facing of one’s fears on the pathway to recovery. 
Physical. Physical activity (exercise) deals with a broad range of health benefits 
such as improving care and decreasing the level of anxiety and depression in cancer 
patients (Stewart, & Wild, 2016). The absence of this can lead to detrimental effects on 
the clients and increase the risk for other conditions other than cancer such as diabetes, 
heart disease, obesity, and hypertension. According to Helgadóttir, Forsell, & Ekblom, 
(2015), physical activity is linked with an improved physical health as well as the life 
satisfaction of patients and their well-being. One of the systematic review studies by 
Stonerock, Hoffman, Smith, & Blumenthal (2015), supported the use of exercise as a 
treatment for depression and indicated that activity relates positively to antidepressant 
medications for mild to moderate depression. Exercise has again been shown to improve 
depressive and anxiety symptoms when used as an adjunct to medicines (Danielsson, 
Noras, Waern, & Carlsson, 2013). 
Physical therapy according to (Carek, Laibstain, & Carek, 2011) is usually linked 
with declined level of anxiety and depression. Physical therapy according to Carek et al., 
(2011) releases chemicals in the body that makes people feel good and relax and 
therefore the advice is practice the exercises such as only walking for 10 minutes and one 
will have his or her symptoms assuaged. 
Meditation. Meditation is one of the mental strategies that could be employed by 
patients undergoing radiotherapy of the breast to manage depression and anxiety (Goyal, 
Haythornthwaite, Levine, et al., 2010). Many cancer patients meditate to lessen the stress 
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them and to forget about the health-related pain they undergo (Khoury, Lecomte, Fortin, 
et al., 2013). The characteristics of meditative techniques are accentuating mindfulness, 
attentiveness, and self-transcendence (Travis & Shear, 2010). Typical techniques, such as 
mystical meditation, emphasize the use of an intonation in such a way that it transcends 
one to an effortless state where focused attention is vague (Chiesa & Malinowski, 2011).  
Another technique is mindfulness, and this is seen to improve the quality of life of 
patients and simplify the symptoms of both anxiety and depression. Other meditative 
practices are assimilated into a wider marginal approach that includes dietary and 
movement therapies (Goyal et al., 2010). 
Spirituality. The term spirituality is the cognizance of a power greater than the 
individual self that gives purpose and meaning to the life (Geffen, 2010). It is the sense of 
touch with the spiritual self and espousal of the connectedness to a higher authority. 
According to Kessler, Wischnewsky, Michalsen, et al., (2013), spirituality is a journey 
where an individual learns about the inner self, and then desires to be connected to the 
Supreme Being and such route is believed to help accomplish peace of mind and healing 
from within. According to the authors, this is achievable when anxiety, and depression, 
which succeed in a wobbly and a nomadic mind, will cease to exist. 
The word ‘Cancer’ stimulates a spiritual crunch in many clients undergoing 
treatment, and for these individuals, the feeling of anxiety, anger, and depression is 
discouraging (Romero, Friedman, Kalidas, et al., 2006). As these patients explore to find 
the actual meaning in their lives and relationships, spirituality becomes helpful and 
therapeutic especially in the African context (Gibson, & Hendricks, 2006). According to 
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Puchalski, (2012), there are enormous benefits of integrating spirituality into cancer 
treatment, and this includes decreasing the level of anxiety, anger, discomfort, loneliness, 
depression, and risk of suicide for patients. According to Hofmann et al. (2010), 
spirituality can play a fundamental role in the healing of patients with anxiety and 
depression. One of the therapies within the African context is spirituality, and this is 
essential because many people attach a spiritual meaning to whatever they go through 
especially with a diagnosis of cancer (Kyei et al., 2015).  
Pharmacological. Contemporary pharmacological treatments for anxiety and 
depression according to Farach, Pruitt, Jun, et al., (2012) are safer and more tolerable 
than previously used, though the effectiveness of the treatment and duration have not 
improved in most cases. Currently, there are pharmacological approaches for the 
management of depression and anxiety in dementia patients, but this according to Gitlin, 
Kales, & Lyketsos, (2012), the side-effects could be bad that it makes the overall 
treatment fundamentally ineffective. Medications could also be therapies for the 
treatment of depression and anxiety. Reich, et al., (2008) indicated that drugs with 
selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake 
inhibitor (SNRI) help in the management of depression and anxiety in breast cancer 
patients. There could also be a combination of psychotherapy and medication treatment 
in achieving this. Finally, Antidepressant drugs may be administered to help treat both 
anxiety and depression.   
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Validity of Anxiety and Depression Symptoms Scales 
A search of the literature on the scales for measuring anxiety and depression took 
place on various search engines. This search found out how important this quest was in 
meeting the goals of the research and whether some key advantages or shortfalls could 
improve the proposed scales for this study as seen in the methodology. Few of the scales 
that the investigator had come across were the Mood and Anxiety Symptom 
Questionnaire (MASQ) initially by Watson & Clark, (1991) but modified in several 
studies (Lee, Kim & Cho, 2015). The other was the Depression Anxiety Stress Scale by 
Fernando Gomez (Henry & Crawford, 2005). Others are the Hamilton Anxiety Rating 
Scale (Shear et al., 2001), the Dukes Anxiety-Depression Scale (Parkerson Jr & 
Broadhead, 1997), and much more. 
Summary 
This chapter reviewed all items regarded as significant in the study. It started with 
a search for all the literature on the topic, followed by an identified gap in literature 
within Africa and particularly at the study center. The theoretical framework developed, 
and the investigator proposed HAPA for the assessment of anxiety and depression. The 
investigator reviewed the influence and the alignment of HAPA with the study. There 
was also a major review of breast cancer in the Ghanaian populace, the culture, 
contributing factors, and the impact on the study. There was also a discussion of the cost 
of breast cancer which is a significant burden to patients. The investigator again looked at 
the risk, diagnosis, causes, prevalence, symptoms and the interventions of breast cancer 
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within the country and beyond. Finally, there was a review of the validity of the scales to 
be used. 
 The next chapter focused on the methods employed for the study. The gap in the 
literature studies centered on assessing levels of depression and anxiety and how this 
assessment impacted treatment outcome for breast cancer patients undergoing 
radiotherapy. With the use of the mixed method design, the investigator focused on the 
evaluation using both quantitative and qualitative pathway, and this could possibly affect 
the overall treatment of patients. 
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Chapter 3: Methodology 
Introduction 
Through this study I aimed to find various interventions for depression and 
anxiety among breast cancer patients in Ghana. I used a combination of qualitative and 
quantitative data through a concurrent triangulation involving an interview with some 
selected professional participants and a detailed survey. The triangulation method was to 
show how the interviews supported, confirmed, or disconfirmed the responses from the 
patient participants. This mixed method approach had a higher weighted scale of the 
quantitative segment with both closed and open-ended questionnaires. I present the data 
collection, data management, and data analysis in this chapter together with a discussion 
of ethical issues of the research.    
Research Methodology 
The study approach was a mixed method design to gather both quantitative and 
qualitative data with a primary concern for quantitative data. The qualitative data were 
interviews with selected staff who worked in close collaboration with patients (doctors, 
nurses, and radiation therapists). The quantitative data was a descriptive survey with 
questionnaire using a sample of 100 participants and with a non probabilistic approach 
because there was no appointment system for patients undergoing treatment for the 
assessment. Patients were selected when they commenced treatment and consented to 
partake in the study. 
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Setting and Sample 
The study took place at the oncology unit of the Korle-Bu Teaching Hospital, 
Accra, Ghana between the proposed months of June and July 2017. The Korle-Bu 
Teaching Hospital is the nation’s primary referral unit for cancer management with an 
approximately 2,000 hospital bed capacity. I chose this for the study site because it serves 
a total of 70% of all cancer cases seen in the country according to Kyei, Opoku, Antwi, 
and Engel-Hills (2015). The use of convenience sampling occurred for the study because 
it offered me access to both the participants (patients and professionals) and data 
required. I used a power analysis to determine the appropriate sample size for the study 
using G*Power 3.1 software (Faul, Erdfelder, Lang, & Buchner, 2007) as shown in to 
Figures 2 and 3 below. The computed sample size was 89 with a power of 0.98.  
 
 
Figure 2. Computing sample size. 
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Figure 3. Range of values for 3-Power analysis. 
 
Research Questions and Hypothesis 
The research questions for this study were 
RQ1-Qualitative: What are the experiences of breast cancer patients undergoing 
radiotherapy with high-level anxiety and depression?  
RQ2-Quantitative: How does the effect of breast cancer stage, the cost of 
treatment, and waiting time affect a patient’s level of anxiety, depression, and 
treatment responses?  
H0: There is no significant relationship between the responses of breast cancer 
patients on their treatment and their level of anxiety and depression and 
treatment response. 
H1: There is a significant relationship between the responses of breast cancer 
patients on their treatment and their level of anxiety and depression and 
treatment response. 
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Qualitative Interviews and Quantitative Survey 
Interviews with six selected participants formed the qualitative aspects of this 
study. These interviews involved semi structured questions asked of the chosen 
participants (two in each professional category). The selected members included two 
radiation oncologists, two radiotherapists, and two oncology nurses who worked in close 
collaboration with the patients. On a daily basis, these participants reviewed, treated, and 
managed patients undergoing breast cancer treatment and therefore had a stake in the 
assessment of these patients. The questions elicited the opinions of the professional 
participants on the different levels of interventions designed for the patients at various 
points in the treatment trajectory.  
The quantitative part of the study consisted of 100 selected participants who fell 
under the inclusion criteria. The formula that was used to verify the minimum sample 
size was n = [Z²p (1-p)]/E², where, n = minimum sample size, p = population proportion 
of the breast cancer patients available during the time of the study, Z = confidence level 
usually defined as 95%, and E = the maximum allowable error (5%). According to the 
Department Registry at the Oncology Unit of Ghana, Accra, an average of 140 patients 
begin treatment every month. Out of 140 patients, an average of 65 are breast cancer 
cases. Hence, within 3 months, a total of 195 patients will typically undergo radiation 
treatment. The breast cancer population proportion for the three months was therefore 
195/420. Therefore, N = [0.95² (195/420 (1-195/420)]/.05², and the minimum sample size 
was N =89.7, approximately 90. Hence, the selected sample size was 100 for the period 
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of the study. The close-ended questionnaire was distributed to the selected patients and 
collected after completion.   
Participant Selection 
The selection of the professional participants was from a pool of over 30 staff 
with a minimum work experience of 5 years. The reason was that with 5 years’ 
professional experience, the staff should be able to assess patients thoroughly, manage 
treatment symptoms, and perform complete treatment for breast cancer patients. 
Recruitment of patients was through the eligibility and exclusion criteria. 
The eligibility criteria for the 100 patients were that 
• the patient was diagnosed with breast cancer, 
• the patient was undergoing radiotherapy, 
• the patient was above 18 years of age, 
• the treatment had lasted for a minimum of three weeks, and  
• the patient was mentally competent to answer the questions.  
The exclusion criteria were: 
• non resident Ghanaians;  
• poor performance status regarding the stage of the breast cancer and effect on 
the participant, such as metastasis to other parts of the body, resulting in an 
inability to respond to the questionnaire appropriately; and 
• worse diagnosis where the patient previously diagnosed with a cancer was in 
the declining, most severe stages of disease, and the resulting pain would 
prevent participation. 
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Role of the Researcher 
I was an observer, and though I am a radiotherapist, I was not involved in the 
treatment of breast cancer patients during the time of the study. I was involved neither in 
the review process of the patients nor the simulation of the patients at the date of the 
survey. The senior radiotherapists on post at the time of the study selected the patients; 
therefore, possibility of researcher bias was significantly minimized. 
Data Collection 
I collected data for the study using a semi-structured questionnaire that was a 
modified version of Patient Health Questionnaire and Depression Anxiety Stress Scale 
(Appendix A). Usually, patients scheduled for treatment are called from the waiting room 
to the control room to prepare for their treatment. The administration of the questionnaire 
took place in the control room where patients are called before to the commencement of 
any procedure. Patient demographics such as the age, sex, education, marital status, and 
income level were measured and used as independent variables. The period of treatment, 
waiting times, type of cancer, and the remedy for the anxiety and depression experienced 
were measured as well.  
Qualitative data were information from participants collected through the 
interviews. The British Educational Research Association (2009), indicated that 
interviews are the best way of seeking the views of other people. Open-ended questions 
through conversations in a format of mutual understanding occurred among the 
participants, allowing them to express themselves (Appendix C). These interviews 
encouraged members to share and provide different opinions about anxiety and 
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depression as they took care of breast cancer patients. The time for the meetings was 15 
minutes for each of the selected participants   
Data Management and Analysis 
Interview data were analyzed using the NVivo version 11 for Mac by QSR 
International through transcribing, finding emerging themes, coding, and making 
connections to the research questions. For the quantitative analysis, the hypotheses were  
H0: There is no significant relationship between the responses of breast cancer 
patients on their treatment and their level of anxiety and depression and 
treatment response. 
H1: There is a significant relationship between the responses of breast cancer 
patients on their treatment and their level of anxiety and depression and 
treatment response. 
The quantitative data analysis used SPSS version 21 to evaluate the relationships 
between the responses of breast cancer patients on their treatment and their level of 
anxiety and depression. I performed multiple regression analyses on the quantitative data 
as this was appropriate whenever there was a desire for the predictive value of a 
correlation between variables (Gravetter & Wallnau, 2013). Responses in frequencies for 
the questionnaire were determined and presented in the forms of tables and graphs. 
Again, I assessed the normality of the distribution of variables through physical 
examination for outliers and the analysis of the skewness and kurtosis for the measures of 
anxiety and depression. I again performed multicollinearity to determine depression and 
anxiety between the independent variables (age, sex, education, marital status and income 
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level). Finally, I conducted a multiple regression analysis to test the hypotheses and the 
regression analysis to test for interactions between the variables and anxiety and 
depression. 
Validity and Reliability 
The study did not involve any experiment nor any threats to internal validity. It 
was, however, possible that threats to statistical conclusion validity could take place 
when the investigator makes insufficient inferences and generalizes the results to the 
whole population. Again, I anticipated that with little statistical power, the effect size 
being estimated was biased, or the statistical assumptions were violated, or even when the 
size of the sample was too small (Marczyk, DeMatteo, & Festinger, 2005). Again, there 
is a potential for a little statistical power when the instruments are unreliable and 
endangerment of the statistical conclusion validity. However, all the tools selected for the 
study were thoroughly reviewed for psychometric adequacy and assessed to evaluate 
internal consistency using Cronbach’s coefficient alpha. 
Ethical Review 
I obtained ethical approval for the study from the Institutional Review Board 
(IRB) of Walden University, and all efforts were made to ensure and uphold this. With 
adult patients to be selected for the survey, the anticipation was that the risk might be 
minimal, protect their identity upholding the Helsinki declaration. However, support 
services were readily available for participants in case of any need of any further 
clarification about their level of anxiety and depression.  
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In this study, the participants involved human beings, and therefore it was 
essential to observe ethical principles as indicated by Burkhart & Pawlik, (2017). The 
investigator considered the basic principles of ethics during data collection, and this 
involved the respect for autonomy, the respect for privacy and confidentiality, the need to 
consider a risk of harm, and the need to avoid deceits or exploitation. The use of a 
voluntary informed consent in this study indicated the participant’s agreement to 
participate in the research with a full understanding of the purpose and implications of the 
study. This consent according to Burkhart & Pawlik, (2017) included disclosure, 
comprehension, voluntary and competency. 
Respect for Autonomy 
As indicated earlier on, the investigator sought consent from the participants 
(professional and patients) and ensured that participants understood the intent of the study 
and were willing to participate. The process of consent for the participants were both 
written for the patients, and verbal and written for professionals. Participants could 
withdraw from the study at any time without prejudgment.  
Respect for Privacy and Confidentiality 
Privacy deals with access or information about participants whereas 
confidentiality relate to the way the researcher treats information about participants in the 
study (Geana, Erba, Krebill, et al., 2017). Lancaster, (2017) indicated in a study that 
attaining direct entry to one’s information and personal issues without any knowledge 
and approval from them becomes a breach of the individual’s privacy. Lancaster, 
however, explained that the breach of confidentiality of the individuals occur when 
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investigators obtain their data or information without their consent. This investigator 
considered privacy and confidentiality as a priority in the study and participants were 
assured of the high level of privacy. Participation was confidential and voluntary, and it 
had no detrimental effect on their overall treatment should any patient decide to 
withdraw. 
The Need to Consider Risk of Harm 
A risk is any prospective harm involving the physiological and psychological 
structures such as distress, injury, and loss of self-esteem (Dooley, Slavich, Moreno, & 
Bower, 2017). Assurances of protection against any physical discomfort and harm during 
the process occurred.  
The Need to Avoid Deceit and Exploitation 
The investigator explained the purpose of the study to participants to rule out any 
form of deceits and exploitations of participants. Granek, Nakash, Cohen, Ben‐David, & 
Ariad, (2016) have indicated in their study, that members could make incorrect 
assumptions when the explanation of the purpose and the process are incomplete. 
The investigator sought approval for this dissertation from the Walden University 
IRB before the beginning of data collection and the Oncology Unit of the hospital in 
Ghana. Rudestan & Newton, (2015. p. 313) are of the view that for research to be carried 
out, the researcher is required to obtain authorization from the IRB at the institution 
where the candidate is enrolled and the sites where the research would take place. The 
Walden University, therefore, requires that students engaged in dissertation writing 
submit their proposals to the IRB for approval before data collection. The submission was 
47 
 
 
to ensure that the student complies with the University's ethical standards as well as U.S. 
federal regulations (Walden University, n.d). The IRB approved the proposal on July, 6, 
2017 (IRB approval no: 06-07-17-0475898). The oncology unit also required that before 
any information on a patient undergoing radiation treatment goes out, approval is sought 
to protect the privacy of the patient and this was done appropriately. 
The investigator would keep the data in a locked cabinet for seven years as 
required by the American Psychological. There was a test for all assumptions and 
conducted accurately and honestly during data collection, data analysis as well as data 
interpretation of the data. 
Summary 
The investigator used interview and a survey to answer the research questions 
using six participants for the interviews whereas 100 patients for the survey. The sample 
size for the quantitative study was determined using a power analysis and verified with 
power analytic framework (Faul et al., 2007). The minimum number of participants from 
the power analysis required for the study was 89. 
After these applications, the Walden IRB gave permission to commence with the 
study, and followed with data collection. Participants were only permitted to take part in 
the study after they had given informed consent and permission. The patient participants 
completed the survey while the professional participants signed the consent forms as 
proof of their approval. The investigator will keep the consent forms locked to assure 
confidentiality. The findings were presented in Chapter 4 representing the results of the 
study, both qualitative and quantitative. 
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Chapter 4: Results 
Introduction 
The purpose of this study was to find various interventions for depression and 
anxiety among breast cancer patients undergoing radiation treatment in Ghana. The study 
explored a combination of qualitative and quantitative data through a concurrent 
triangulation involving semi structured interviews with selected professional participants 
and a detailed survey. The reason for the choice of the mixed method was to explore 
potential causes of anxiety and depression among breast cancer patients and map some 
interventions for them. The research questions that guided the study with the hypotheses 
are repeated in this section to guide the analysis. The research questions and hypotheses 
were: 
RQ1-Qualitative: What are the experiences of breast cancer patients undergoing 
radiotherapy with high-level anxiety and depression?  
RQ2-Quantitative: How does the effect of breast cancer stage, the cost of 
treatment, and waiting time affect a patient’s level of anxiety, depression, and 
treatment responses?  
H0: There is no significant relationship between the responses of breast cancer 
patients on their treatment and their level of anxiety and depression and 
treatment response. 
H1: There is a significant relationship between the responses of breast cancer 
patients on their treatment and their level of anxiety and depression and 
treatment response. 
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In this chapter I summarize the data collection procedure, describes the preparation of the 
data for analysis, and provides the results of the analyses. 
Data Collection and Management 
Data collection began on Thursday, June 8, 2017, at exactly 9:23 am GMT and 
ended on July 13, 2017, at 3:12 pm GMT. On the first day of the study, I distributed 
seven questionnaires to patients after they consented to participate in the study. The data 
collection continued through the whole study until the last patient participant completed 
the survey on July 13, 2017. I collected the qualitative data through face-to-face 
interviews from June 29, 2017, and on July 4, 2017, in the afternoons, beginning with the 
oncology nurses, followed by the radiotherapists, and finally the oncologists. 
After data collection, I entered the responses of the questionnaires into SPSS 
version 21. I screened the data, scored the instruments and conducted statistical analysis. 
As described in Chapter 3, a power analysis using G*Power 3.1.9.2 software and a 
minimum sample size calculation were both used to determine the appropriate sample 
size for the study (Faul et al., 2007). Both items indicated that a minimum sample size of 
89 was required.  
Coding Analysis 
I recorded the interviews on a phone device, and the audio files were in English. I 
listened to each of the recordings a minimum of seven times and documented them on in 
a Word document (Appendix E-J). I imported the interview materials into the NVivo 
software version 11. I then opened them and explored all six participants, grouped them 
into categories such as doctors, nurses, and radiotherapists. Initially, I identified the 
50 
 
 
responses to each interview question and then related them to the research question. I 
then coded each transcript using an inductive coding approach from by Thomas (2006) in 
which the investigator teases out important themes from raw data.  
Themes 
I generated the themes as I read and reread the transcripts of the interview 
documents. Following this, I carefully analyzed the interviews with the research question 
and formed themes including complaints from patients, the cost of treatment, fear of the 
unknown, the burden of the disease, spirituality, the need for psychotherapist, and several 
others. Some of the coding categories changed after consideration of the data. When I 
identified a new code or deleted a code, I went back to the particular transcript to reread 
and make the appropriate changes as described by Campbell, Quincy, Osserman & 
Pedersen, (2013). I visualized by displaying some of the word on word tree (Figure 8). I 
conducted text search for some words to see the frequency of them from the participants. 
I did a matrix coding and comparison for some of the items. Finally, I recorded all the 
insights drawn from these analyses and used them for the write up of the discussion of the 
study.  
Research Findings 
The following sections present the results of the study. The first section displays 
the qualitative data from the NVivo while the other shows the quantitative data from the 
SPSS. I further divided these sections into sub sections. There were five subsections for 
the qualitative data. These were the participant demographics information such as gender, 
profession, and years of practice. The other sub sections display the discussion on 
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complaints, solutions prescribed, feedback from patients, and the management. All these 
sub sections answered the first research questions. The quantitative data section was 
divided into four main sub sections. The first displays socio demographic data, followed 
by anxiety and depression about treatment, and interventions for management. This 
section answered the second research question. 
Qualitative Data 
Descriptive Statistics for the Interviews 
Table 2 provides the demographics for the responses given by professional 
participants. I de-identified the participants using pseudonyms. In all, 33.3% of 
participants were females, and 67.7% were males. The results showed that the 
oncologists interviewed had the least numbers of years of professional experience. 
Table 2 
Participant’s Demographics  
Gender  Profession Years of Practice 
Male Doctor (oncologist) (D1) 5-6 
Male  Doctor (oncologist) D2) 5-6 
Male Radiotherapist (R1) 9-10 
Female Radiotherapist (R2) 5-6 
Female Nurse (N1) 7-8 
Male Nurse (N2) 7-8 
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Research Question 
RQ1 was: What are the experiences of breast cancer patients undergoing 
radiotherapy with high-level anxiety and depression? The collection of data from the six 
participants interviewed answered the research question above. I asked a series of 
questions from the three categories of profession chosen (Appendix C). The questions, 
though similar, were categorized. To determine what form of management or 
interventions patients received for their level of depression and anxiety, I asked the 
participants (D1, D2, R1, R2, N1 and N2) about their reviews, treatment sections, and 
radiotherapy delivered to patients. Again, discussions on the interventions of depression 
and anxiety was discussed thoroughly.  
I generated themes from the responses received and read and reread transcripts 
several times to make meaning of the responses of the participants. Some the themes that 
emerged were (a) complaints from patients, (b) the burden of the disease, (c) waiting 
times, (d) interventions prescribed, (e) feedback for patients, and (f) management of 
depression and anxiety. 
Formation of Themes 
Complaints from patients. There were series of questions during the interview 
on anxiety and depression. I began by asking participants whether they received 
complaints from patients about their level of anxiety and depression. The responses from 
all the participants indicated that breast cancer patients undergoing treatment complain. 
There were frequent complaints that ran through all three categories of persons 
interviewed. The complaints were shared among patients, and some of these were 
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distress, the burden of disease, fear of the unknown, waiting time before treatment, and 
cost of treatment. Others were also specific to the unit where treatment was ongoing. 
However, some of these complaints were profession-dependent, and though the 
interview questions were the same for each of the participants, the responses were 
different from the individual profession. As shown in Figures 4 and 5, all the doctors saw 
the cost of treatment as an indicator of patient anxiety and depression. Again, one the 
nurses talked much about cost and expressed how patients are distressed with the large 
amount of money needed to pay for treatment, though the other nurse did not. One of the 
radiotherapists mentioned cost as an indicator.  
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Figure 4. Participants discussion on patients’ complaints. 
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Figure 5. Participant’s discussion on patients’ complaints on cost of treatment. 
 
The burden of the disease. This was discussed extensively by the participants. 
The burden covered the complaints including the high cost of treatment, distress from the 
disease as well as the daily treatment, and fear of the unknown as well as experiences 
shared by the professionals (Figure 6). 
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Figure 6. The burden of the disease. 
In trying to understand the burden as related to cost, some of the responses were:  
• Their financial commitment to the treatment is high . . . and the chemotherapy 
drugs are very costly . . . and the overall treatment is way too expensive for an 
average Ghanaian. This will be too hard for them. (N2) 
• Financial burden of patients affect the information they receive in the clinic. 
(D2) 
• Patients also complain of the financial burden as they have to pay their 
treatment from the beginning through to the end . . . most of them say they are 
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traders and earn very little and therefore the payment is an issue for them. 
(D1) 
• The disease is affecting their work, and this is affecting their ability to pay 
their treatment cost. (R2) 
Participants again expressed distress from the disease as indicators that could 
result in anxiety and depression. The investigator identified this as a burden of the 
disease, and responses to these were: 
• According to her, she lost her hair, finger nails were burnt, and had several 
issues with the drugs, which was distressing for her . . . She expressed 
concern, anxious, and didn’t know how long she will live. (N1) 
• Exposing themselves especially to male therapists is a big issue for these 
women. (D1) 
• From the information patients provide, staff can tell whether this patient is 
in some distress. After the explanations of the side effects, the patient 
becomes even worse. (R1) 
• So just seeing machines at the treatment unit is enough to scare them 
through their treatment trajectory. (R2) 
For fear of the unknown, one of the professionals expressed it this way: “This in 
effect increases their anxiety and depression as they are constantly afraid.” (N2) With 
their experiences, some also indicated some burden they see on patients. This was how it 
was expressed: 
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• She was anxious about the outcome of the treatment, family life, and coping 
with work . . . She was concern about the darkening of her skin as a result of 
radiation, sore throats, and her ability to go back to work after treatment. (D2) 
• I realized that she was disturbed, and so I decided to talk to her. Money to pay 
bill was a problem, the husband was not in talking terms with her because of 
the burden of the family, besides they got married not long ago. (D1) 
• She was afraid she was going to get a heart attack because somebody told her 
that her heart is close to the area of treatment. (R2) 
Waiting times. A text search done on waiting time (Figure 7) revealed that the 
participants did not mention nor saw waiting times as major complaint from patients. 
 
 
 
Figure 7. Text search on waiting time. 
 
59 
 
 
Interventions Prescribed for Patients 
The section of the question was a kind of response to the complaint from patients. 
The responses indicated the interventions prescribed, discussed or suggested to patients 
undergoing treatment. Grouping them by professions, these were the responses; 
• I try to reassure them of the treatment and counsel them of the fact that the 
side effect is not permanent and that once they finish their treatment, it will 
end. I try to educate them on the disease and the entire procedure. I encourage 
them to go through to the end. (D1) 
• I also prescribe some medications for them sometimes, and some even get 
sleeping tablets because they complain of sleep impairment. I give them the 
right pieces of information, and when I feel I can’t help, I usually refer to the 
appropriate unit. I give assistance in the form of introductory letters on request 
from patients to their work places for financial support. (D2) 
• Explaining what the process is all about, and letting them know that, yes, the 
machine is big and scary, but this is what it does to treatment. I also inform 
them that I am monitoring the while treatment is ongoing and when they talk I 
can hear them and see them, so they should not fear. I usually advise them to 
do something they love doing to take their minds off all the stress. (R1) 
• I inform them that if they are in any form of distress during treatment, they 
should signal me and then I will come to their aid. I usually advise them to get 
used to the treatment within a day or two. I also advise them to get relief or 
excuse duty from work or even take some days off while’s treatment is 
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ongoing to get enough rest to cope with treatment if that will not cause any 
problem for them. (R2) 
• The first stage is the counseling for the patients, I discuss every possible side 
effect to patients . . . I personally also try to debunk any negative information 
they have heard from people concerning the treatment, like “you will die’, 
‘they will cut your breast,' ‘your hair will be gone’ and the likes. (N1) 
• I try to talk to patients often and refer them to the doctors as and when needed. 
(N2) 
Feedback From Patients  
The second question was a follow-up question from the first issue on complaints 
from patients. Results from the feedback as expressed by participants are as follows; 
• Patients usually get better and are less apprehensive in their next visit. (D2) 
• They complain of several side effects that make them weaker and more 
worried even in their next visit. (N1) 
• We have a positive feedback, for example those with financial burden by their 
next visit will be smiling and be cheerful especially when they get support 
from people. Again, by their next chemo visit, even if they may have 
complaints, they will look more friendly, and open-up. (N2) 
• From their next visit or review, most of them become better and their 
confession changes. The anxiety or depression may not be completely gone, 
but they will still be positive. (D1) 
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• Most times, I will say it’s almost 90% positive feedback. Those who do not 
put their minds to the reassurances we give them, of course, continues to have 
issues. (R1) 
• Yes, we do see positive feedback, even from challenging patients if I should 
put it that way. (R2) 
From a word frequency query run, words like patients, treatment, and anxiety were 
outstanding (Figure 8). There were also words like interventions, depression that showed 
up boldly.  
 
Figure 8. Word frequency. 
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Management of Depression and Anxiety 
The management discussed by participants as the interacted with their patients 
were; the need for a psychotherapist, or a counselor, spiritualist or a pastor, physical 
therapist or exercise, and finally medications. 
Psychotherapy. Responses from five out of six participants indicated the need for 
a psychotherapist with the Oncology department in Ghana. These were the responses; 
• One thing that I can think of is that you know in most companies or hospitals, 
they have Psychologists and Cognitive behavioral therapist who help in the 
counseling. (N2) 
• I also believe that oncology department needs a clinical psychologist, it’s 
essential because they can see to these patients separately. (D2) 
• I think that we need psychologists to handle these patients. (D1) 
• I think we should get a psychologist. (R1) 
• I think we need a psychologist who will counsel these patients right from the 
start of treatment. (R2) 
Spiritual. Two participants mention pastors and prayer. 
• I also see pastors in the morning praying with some of the patients and I 
believe that also help with those who believe in these. (N1) 
• I talk to them about their spirituality because of what I believe. Of course, we 
have variety of patients, some are Christians, Muslims, and other 
traditionalists, but I try to let them know that cancer diagnosis is not a death 
sentence and that is not the end of the world. (N2) 
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Physical therapy. Two of the participants spoke about the need for 
physiotherapy. 
• Education on patients should be all round through the treatment and counsel 
them to exercise if possible to get some relief. (D1)  
• I encourage them to exercise if they can. (R2) 
Pharmacological: One of the doctors mentioned about prescription of drugs for 
patients at some point 
• I also prescribe some medications to take care of the anxiety, and depression, 
some even get sleeping tablets because their sleep is impaired. (D2) 
The Table 9 summarizes all the results discussed in this chapter on the interviews 
conducted. 
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Figure 9. Summary of participant interviews (N = 6). 
Quantitative Data 
Descriptive Statistics for Demographics 
The Table below provides the socio-demographic characteristics for the responses 
given by the 100 patient participants. The age group of 50-59 years had the highest 
frequency of 28% whiles the least was 80-89 years. All the participants (n=100) were 
females with the Akan tribe with the highest rate of 37%. Those married had the highest 
frequency (73%). With the employment status, 51% of the participants were full-time 
workers. Forty-one percent were not into any job as well. In all, 89% had no family 
history of breast cancer and the majority (55%) had the disease duration of one to three 
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Interview with Participants
1 : Interview with Nurse Enam on the 30th June 2017
2 : Interview with Nurse Reginald on the 29th June, 2017
3 : Interview with Doctor Ntiamoah on the 4th July 2017
4 : Interview with Doctor Asamoah on the 30th June 2017
5 : Interview with RTT Osei on the 30 June 2017
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years. Finally, 41% of participants had a monthly income of less than a thousand Ghana 
Cedis (which is less than 300 USD). 
Note. The n’s do not always add up to 100 or a percentage of 100 because some of the 
patients decided not to answer some questions. 
Table 3 
 
Socio-demographics characteristics 
 
 
Characteristic 
Frequency 
(n = 100) 
Percentage (%) Cumulative 
percent 
Age-group (YRS) 
 
20-29 
                
                4 
4.0 4.0 
 
30-39 
                 
               22 
22.0 26.0 
40-49                 19 19.0 45.0 
50-59                      28 28.0 73.0 
60-69                 17 17.0 90.0 
70-79                   9 9.0 99.0 
80-89                   1 1.0 100.0 
    
Family history 
YES 
NO 
                 10 
                 89 
10.0 
89.0 
                      10.0 
                                
99.0 
 
   
 
Tribe 
AKAN 
GA-ADANGBE 
EWE 
NORTHERN 
                 37 
                 29 
                 19 
                 15 
37.0 
29.0 
19.0 
15.0 
37.0 
66.0 
85.0 
100.0 
 
 
 
Weight (KG) 
31-50 
51-70 
71-90 
91-110 
>110 
7 
36 
43 
12 
2 
7.0 
36.0 
43.0 
12.0 
2.0 
 
7.0 
43.0 
86.0 
98.0 
100.0 
 
 
 
 
  Table continues 
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Characteristic 
      Frequency  
       (n = 100) 
    Percentage 
(%) 
      Cumulative       
percent 
Marital status 
 
SINGLE 
MARRIED 
DIVORCED 
WIDOWED 
 
11 
73 
5 
11 
 
11.0 
73.0 
5.0 
11.0 
 
11.0 
84.0 
89.0 
100.0 
Disease duration < 1 YEAR 
B/N 1 &3 
YEARS 
> 3 YEARS 
13 
55 
31 
 
13.0 
55.0 
31.0 
 
13.0 
68.0 
99.0 
 
Employment 
status  
 
FULL TIME 
PART TIME 
UNEMPLOYE 
RETIRED 
STUDENT 
 
51 
6 
3 
36 
3 
 
51.0 
6.0 
3.0 
36.0 
3.0 
 
51.0 
57.0 
60.0 
96.0 
99.0 
Monthly income 
(GH) 
 
NIL 
100-999 
1000-1999 
2000-2999 
3000-3999 
41 
21 
27 
5 
3 
 
41.0 
21.0 
27.0 
5.0 
3.0 
 
41.0 
62.0 
87.0 
92.0 
3.0 
 
Descriptive Statistics for the Questionnaire 
The Table below provides the socio-demographic characteristics of the responses 
given by the 100 patient participants. The age group of 50-59 years had the highest 
frequency of 28% whiles the least was 80-89 years. All the participants (n=100) were 
females with the Akan tribe with the highest rate of 37%. The married had the highest 
frequency (73%). With the employment status, 51% of the participants were full-time 
workers. Forty-one percent were not into any job as well. In all, 89% had no family 
history of breast cancer, and the majority (55%) had the disease duration of one to three 
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years. Finally, 41% of participants had a monthly income of less than a thousand Ghana 
Cedis (which is less than 300 USD). 
Table 4  
 
Descriptive statistics for the questionnaire 
 
 
 Age Weight Tribe 
Marital 
status 
Employm
ent 
status 
Monthly 
income 
Disease 
duration 
Family 
history 
N Valid 100 100 100 100 99 97 99 99 
Missing 0 0 0 0 1 3 1 1 
Mean 3.63 73.60 2.46 2.16 2.33 1.25 2.18 1.92 
Std. Error of 
Mean 
.139 1.657 .151 .076 .149 .152 .065 .031 
Median 4.00 72.00 2.00 2.00 1.00 1.00 2.00 2.00 
Mode 4 60a 1 2 1 0 2 2 
Std. Deviation 1.390 16.567 1.514 .762 1.478 1.493 .645 .309 
Variance 1.932 274.465 2.291 .580 2.184 2.230 .416 .095 
Skewness .117 .429 .586 1.260 .334 1.519 -.187 -2.006 
Std. Error of 
Skewness 
.241 .241 .241 .241 .243 .245 .243 .243 
Kurtosis -.728 .089 -1.252 1.642 -1.749 2.645 -.625 6.187 
Std. Error of 
Kurtosis 
.478 .478 .478 .478 .481 .485 .481 .481 
Range 
6 84 4 3 4 7 2 2 
 
 
a. Multiple modes exist. The smallest value is shown   
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Table 5 
 
Bivariate analysis of factors associated with Anxiety and Depression 
 
Characteristics                               X2                          P 
Age-group 1.02 0.002 
Tribe 0.015 0.211 
Marital Status 0.375 0.85 
Employment Status 0.032 0.914 
Monthly Income 1.47 0.5 
Disease Duration 9.38 0.136 
Family History 0.51 0.78 
   
   
 
The chi square of the monthly income of patients with anxiety and depression was 1.47, 
and the p-value was 0.5. This indicates that income of patients has an effect on anxiety 
and depression. 
Table 6  
 
Anxiety and Depression on Life Frequencies 
 
 
Responses 
N Percent 
Anxiety and Depression on treatment not at all 46 5.1% 
Occasionally 414 46.1% 
quite often 327 36.4% 
very often 111 12.4% 
Total 898 100.0% 
 
          
        a. Group 
With 898 responses on anxiety and depression, 46.1% were occasional and 12.4% were 
very often.  
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Table 7  
 
Anxiety and Depression on Treatment Frequencies 
 
 
Responses 
           N Percent 
Anxiety and Depression on life not at all 313 17.4% 
several days 778 43.3% 
more than half the days 556 30.9% 
nearly everyday 150 8.3% 
Total 1797 100.0% 
 
 
a. Group 
Out of the 1797 responses received from patients on anxiety and depression about their 
life while on treatment, 43.3% indicated several days. 
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Table 8 
 
Regression Analysis 
 
 
 
 
 
 
 
 
 
 
 
B. Model Summaryb 
 
Model R R Square 
Adjusted R 
Square 
Std. Error of 
the Estimate 
Change Statistics 
R Square 
Change 
F 
Change df1 df2 
Sig. F 
Change 
1 .397a .158 .078 4.412 .158 1.988 8 85 .058 
A. Predictors: (Constant), Family History, Age, Disease Duration, Tribe, Weight, Marital Status, Monthly 
Income, Employment Status 
B. Dependent Variable: Anxiety And Depression On Treatment 
 
 
 
Table continues 
 
A. Descriptive Statistics 
 
         Mean           Std. Deviation                    N 
Anxiety and depression on 
treatment 
14.36 4.595 94 
Age 51.32 13.641 94 
Weight 72.76 16.063 94 
Gender 2.00 .000 94 
Tribe 2.49 1.515 94 
Marital status 2.19 .766 94 
Employment status 2.38 1.496 94 
Monthly income 1.21 1.502 94 
Disease duration 2.22 .658 94 
Family history 1.93 .302 94 
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B. ANOVAa 
Model          Sum of Squares Df Mean Square F Sig. 
1 Regression 309.457 8 38.682 1.988 .058b 
Residual 1654.246 85 19.462   
Total 1963.702 93    
a. Dependent Variable: Anxiety And Depression On Treatment 
b. Predictors: (Constant), Family History, Age, Disease Duration, Tribe, Weight, Marital Status, Monthly 
Income, Employment Status 
 
 
C.  Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
T Sig. 
95.0% 
Confidence 
Interval for B 
Collinearity 
Statistics 
B 
Std. 
Error Beta 
Lower 
Bound 
Upper 
Bound 
Toler
ance VIF 
1(Constant) 24.223 5.137  4.716 .000 14.009 34.436   
Age -.094 .042 -.280 -2.269 .026 -.177 -.012 .653 1.532 
Weight -.037 .030 -.130 -1.229 .222 -.097 .023 .892 1.121 
Tribe .486 .313 .160 1.554 .124 -.136 1.107 .933 1.072 
Marital Status .940 .635 .157 1.479 .143 -.324 2.203 .884 1.132 
Employment Status -.431 .488 -.140 -.884 .379 -1.400 .538 .393 2.543 
Monthly Income -.923 .443 -.302 -2.081 .040 -1.805 -.041 .472 2.119 
Disease Duration .528 .710 .076 .743 .460 -.885 1.940 .957 1.045 
Family History -2.403 1.566 -.158 -1.535 .129 -5.515 .710 .937 1.068 
a. Dependent Variable: Anxiety And Depression On Treatment 
 
Age (B = -0.094, ß =-0.280, t = -0.269, p < 0.05), and monthly income (B = -
0.923, ß =-0.302, t =-2.081, p < 0.05) were statistically significant in predicting the 
anxiety and depression among the patients as compared to the rest of the variables. The 
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beta value for disease duration, marital status, and tribe indicate that anxiety and 
depression on treatment increases respectively holding all other variables constant (0.76, 
0.157, 0.160) showing a positive relationship. The VIF is less than 3 for all variables, 
meaning that there is a positive correlation. Hence, the assumptions are met, and 
therefore the conclusion is that the independent variables are not confounding. All other 
things equal, these lower levels of VIF, indicate a positive effect on anxiety and 
depression associated with a multiple regression analysis.  
From Table 8, R (0.397) was found to be less than 0.5, indicating that there is a 
change in the model. The alternate hypothesis is therefore accepted since the independent 
variables significantly predicted anxiety and depression. An ANOVA was conducted for 
anxiety and depression as the dependent factors and demographic as the predictors.  
Intervention of Anxiety and Depression 
A greater percentage (30.7%) of the patients indicated meditation as their 
intervention while few (9.1%) were of the view that their doctors referred them for 
counseling (Figure 10). 
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Figure 10. Interventions of anxiety and depression, n = 100. 
Summary 
The chapter presented the results of the findings. The first data was qualitative 
with typing the recorded data of the six participants into word and transporting them into 
the NVivo. Coding analysis followed by formation of emerging themes, visualization of 
results, and finally, recording all insights from analysis into write up. The quantitative 
part of the study described the demographics, and I conducted a descriptive statistics. I 
performed a bivariate analysis of factors associated with anxiety and depression for the 
independent variables. There was also a Regression analysis comprising Anova, and 
coefficients of variables such as Age, and monthly income were statistically significant in 
28.30%
56.60%
94.90%
88.90%
40.40%
INTERVENTION OF ANXIETY AND 
DEPRESSION
MY DOCTOR HAS REFERRED
ME TO CBT FOR COUNSELLING
THERAPIST HAVE ADVICED ME
TO EXERCISE WHEN
DEPRESSED
I MEDITATE WHEN
DEPRESSED
I PRAY WHEN DEPRESSED
I HAVE  BEEN ADVICE TO TAKE
MY MEDICATION WHEN
DEPRESSED
74 
 
 
predicting anxiety and depression. The R (0.397) value was less than 0.5, which depicted 
that the alternate hypothesis could be accepted. The independent variables significantly 
predicted the Anxiety and depression. Finally, I presented the intervention of anxiety and 
depression in a pie chart, and a 30.7% indicated that they meditate whenever they are 
either anxious or depressed. Chapter 5 will further discuss and interpret these results of 
the findings. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
This final chapter is organized into five sections beginning with the introduction. 
The overview consists of a short synopsis of the reasons underlying the purpose of the 
study, and I review the research questions and discuss the findings. I interpret the results 
in the context of the literature reviewed as well as the theoretical framework discussed in 
Chapter 2. The study limitations follow along with recommendations for further research 
and the implications for social change.  
The purpose of this study was to find various interventions for depression and 
anxiety among breast cancer patients undergoing radiation treatment in Ghana. In this 
study I explored a combination of qualitative and quantitative data through a concurrent 
triangulation involving semi structured interview with some selected professional 
participants and a detailed survey. Through this study I sought to address a gap in the 
literature by identifying significant relationships between the responses of breast cancer 
patients undergoing radiotherapy treatment and their various levels of anxiety and 
depression, as well as their treatment responses. The research question for the 
quantitative study looked into how factors such as stage of cancer at presentation, the cost 
of treatment, waiting times, the burden of the disease, and other factors affect the 
treatment responses of patients. The qualitative portion of the study focused on the 
experiences of the patients with their caregivers as they underwent their treatment. 
This study was vital given the scarceness of literature on the subject for Ghana 
and Africa at large. As discussed in Chapter 1, a thorough search of literature conducted 
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among all the research studies identified only a few focused studies. These were on 
assessment of anxiety and depression among breast cancer patients undergoing radiation 
treatment (Srivastava et al., 2016; Hassan et al., 2015; Chintamani et al., 2011; Dastan & 
Buzlu, 2010; Vahdaninia et al., 2010), and none of these studies took place in Ghana or 
even in Africa. The experiences of cancer patients in the African context is different from 
those in the developed countries, and there are few studies on African patients. Most of 
the patients present with late-stage disease, and therefore the focus should be on how to 
manage them. The risk factors associated with anxiety and depression among cancer 
patients have been well documented (Yang et al., 2017; Metcalfe et al., 2013; Lin et al., 
2013). Though limited, none of these studies were conducted in Ghana.  
Issues that confront patients undergoing treatment in Ghana are different from 
what pertains in the Western world. For example, waiting time, cost, and stigmatization 
may not be an issue for a patient in the developed countries, but in Ghana, they are major 
problems. The literature discussed in Chapter 2 revealed that cancer patients in Ghana 
have to pay their cost of treatment because radiotherapy and cancer care are not under the 
National Health Insurance Scheme. The trauma of financial inadequacy coupled with 
long waiting hours before treatment is worrying. Factors such as age, marital status, 
occupation, total monthly income, and tribe play a critical role in determining the level of 
depression and anxiety. A common item noted in this study was the fact that any cancer 
diagnosis could be a very stressful experience for the patient as well as their family as a 
whole. These experiences coupled with the several issues associated with the diagnosis 
such as late presentation, treatment, and survival could pose significant uncertainty for 
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these patients from the onset of diagnosis (Kim, Carver, Spiegel, Mitchell, & Cannady, 
2017).  
Interpretation of the Findings 
Description of the Interviews 
Following RQ1, I examined the experiences of breast cancer patients undergoing 
treatment on their levels of anxiety and depression. The data were from semi structured 
interviews with six participants, two male oncologists with 5-6 years of experience, two 
nurses (a male and a female) with 7-8 years of practice, and two radiotherapists (a male 
and female) with 9-10 years and 5-6 years of experience respectively. The experiences of 
patients as reported by the participants cut across cost of treatment, the burden of the 
disease causing distress in patients, and interventions prescribed.   
Cost of treatment. The results indicated that professional participants received 
complaints from patients especially on distress, the burden of the disease on their life, 
fear of the unknown, cost of the treatment and their waiting times (Figures 5, 6, and 7). 
According to the participants, the burden of the disease resulted from the high financial 
commitment from patients which is one of the indicators of anxiety and depression. 
Treatment cost of breast cancer ranges between $1,000 - $2,000 and the reports from the 
study indicated that such money was too high for average patient. According to the 
participants, this affects the information patients received in the clinic during the review 
and their overall output. Again, the overall treatment cost could be much higher when 
chemotherapy and hormonal therapy are prescribed. These findings were in agreement 
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with the study by Opoku et al., (2012) which indicated that financial burden could 
significantly affect the overall treatment outcome for patients undergoing treatment.  
Responses from the participants (Figure 5) indicated what transpires in the 
oncology setting in Ghana. Doctors usually acquire the consent before the start of 
treatment, which includes discussion on the cost of treatment. This process may explain 
why both doctors mentioned cost as an indicator of depression and anxiety. Some 
therapists and nurses at some point spend time during treatment to further remind patients 
to pay their bills, though this is not mandatory for them to do. This reason may explain 
why some mentioned cast in the interviews and others did not. In the oncology setting in 
Ghana, only doctors are mandated to bill, prepare, and ask patients about their treatment 
bills.  
On the whole, all the participants who mentioned cost from their interactions with 
the patients indicated a high level of pain and trauma resulting from the high cost of 
treatment of breast cancer in Ghana. According to the participants, this burden leads to 
elevated levels of anxiety and depression expressed at different points during their 
treatment regime. These findings were in line with a study by Opoku et al., (2012) that 
indicated patients’ displeasure on the high cost of treatment. Though according to 
Ginsberg et al. (2012) literature on the cost of breast cancer treatment is mostly 
emphasized in the high-income countries, this study showed that cost of treatment is high 
in a middle-income country such as Ghana. A suggestion made by Zelle et al., (2012) 
identified cost-effectiveness analysis as an agent that could help intervene in the cost of 
treatment of breast cancer.  
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In an interview by a popular press firm with an oncologist in Ghana on the cost of 
cancer, Dr. Aryeetey indicated worries about the burden patients go through in the 
payment of their bills (Graphic online, 2015). Dr. Aryeetey expressed observations about 
the high cost of cancer treatment and how it places a burden on many patients, some of 
whom are unable to pay their medical bills. Dr. Aryeetey indicated that many cancer 
patients had abandoned their treatment as a result of the high cost of treatment, 
suggesting that a national cancer fund should be established to contribute towards the 
treatment of cancer in the country to lessen the financial burden on patients. Dr. Aryeetey  
also noted that due to the high cost of treatment, persons diagnosed with breast cancer 
may delay in seeking treatment, reporting later with advanced stages of the disease, when 
very little can be done to promote their survival.  
In another press communication (Financial Times, 2013), a parent expressed 
worries and pointed out that families in Ghana struggled to meet the cost of cancer care 
and pleaded with the government to meet them halfway if possible. He said all his family 
savings had been spent on the treatment, and they had no money left to feed the rest at 
home, resorting to prayer camps for a solution.  
Burden of the disease. As shown in to the Figure 6, the interviews indicated that 
the burden of the disease was the subject of some complaints from the patients under 
treatment. The constitution of the burden included financial commitment, worry about 
whether they will be able to complete treatment because of an inability to pay. Another 
burden that led to distress was the loss of hair, discolored finger nails, and various issues 
with cytotoxic drugs. Hair loss (alopecia), because it is visible to others, can cause 
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considerable distress for patients (Boehmke, & Dickerson, 2005). The crown of hair is 
part of the patient’s self-image and can affect the patient’s confidence as well as the way 
they see themselves (Helms, O'Hea, & Corso, 2008).  
One of the patients expressed her concerns to one of the participants (N1) about 
how upset she was after her hair loss, though she was counseled about it. According to 
Sheppard, & Ely, (2008), losing their hair could be associated feelings of with loss of 
sexuality and desirability by the patients. A recommended solution suggested by the 
Breast Cancer Network Australia (2011) was that patients have to be prepared thoroughly 
by the caregiver before the treatment, and individual patients should talk about it with 
others such as family and friends. This will help patients adjust to their temporary change 
in appearance. Breast Cancer Network Australia also suggested that patients discuss this 
change with their children to prepare them for it, assuring them that their hair will grow 
back. 
On the issue of disfigured and darkening of their fingers and nail beds, N1 spoke 
about it as a complaint from patients, adding that counseling and consent before 
chemotherapy should include this information. Counseling should be provided for the 
patient regarding the changes to fingernails and toenails, pointing out that it is common 
with chemotherapy and assuring the patient that it usually fades a few months after 
treatment. This education could help patients cope with the changes that occur. Some of 
the drugs that cause nail changes include docetaxel, paclitaxel, Adriamycin, 
Cyclophosphamide, and 5-Fluorouracil (5FU), among others, and this should be made 
known to patients undergoing treatment (Canadian Cancer Society, 2017).   
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Participant N1 mentioned issues that impacted on the life of patients undergoing 
treatment. For example, participant N1 indicated that patient complaints included 
problems with some of the chemotherapy drugs. According to the Cytotoxic Safety 
Council (n,d), about 27 chemotherapy drugs are expelled from patients at high 
concentrations, and these could cause severe and irreversible illnesses. Some of these 
damage deoxyribonucleic acid (DNA), resulting in cell death and affecting the growth 
and the development of an embryo, leading to fetal death or defects. 
According to N1, other issues were that patients were anxious about the outcome 
of treatment, family life, and ability to cope with work after treatment. These were all 
vital issues that confronted patients undergoing treatment. One other concern in the form 
of a complaint was sore throats as a consequence of the treatment. Patients indicated to 
D1 their inability to swallow properly as a result of the treatment. This complaint should 
have been discussed in the counseling session for patients before the commencement of 
the treatment. The staging of breast cancer is based on the TNM model, where T stands 
for size, N is for nodal involvement, and M represents metastasis or spread. Any nodal 
involvement will require treatment of the neck and therefore could lead to a sore throat. 
Proper technique of set-up for patients and counseling before the treatment could 
significantly reduce this. Patients should be advised to remain in the same position for 
treatment and cautioned that any movement of the neck while undergoing treatment could 
result in sore throat. Counseling of patients should include the management of sore 
throat, which is gargling salt water regularly, staying hydrated, and drinking warm water 
with lemon (BreastCancer.Org, 2017). 
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Another report from one of the participants was the treatment related fear 
exhibited by patients. According to N1, a patient was told by another patient that she 
would develop cardiac disease secondary to radiation therapy. This information, even 
though not accurate, led to fear, which led to depression and anxiety. Treatment of the 
breast and lymphatic drainage will undoubtedly involve some vital organs such as lung 
and heart. However, the treatment plan with  proper calculation of the doses demonstrates 
how much each organ within the treated field is receiving and ensures that reference 
tolerance levels of each organ at risk is respected (Lawrence, Ten Haken, & Giaccia, 
2008). All these will have to be communicated properly to patients during counseling and 
consent to avoid situations and comments from patients such as these.  
On the waiting time of patients, only one participant (R1) mentioned about some 
complaint about their waiting time from a patient, which in effect led to anxiety. Almost 
all the participants said nothing about waiting time. This finding were inconsistent with a 
study by Kyei & Engel-Hills, (2011) in the same department of the hospital which 
revealed patients were delayed at every point in their treatment, affecting the flow of 
work in the department. The reason given for this was the increasing responsibilities of 
the few Radiation Therapist in the country, as well as the workload of doctors. Currently, 
there has been some improvement in human resource, and adopting appointments based 
treatment schedule and shifts schedule for treating patients possibly may have reduced 
patient waiting time as reflected in the study. 
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Interventions prescribed for patients and their feedback 
These were various intercessions made by the professional participants for 
patients whiles they were on treatment. These were reassurances, explanations of the 
entire treatments and side effects, and counseling. Other interventions were 
encouragement, advice (such as doing something they love doing, get relief from work, 
and relaxation), monitoring, coping, debunking any negative pieces of information from 
them, prescriptions for medications, and on few occasions, referring to counsellors 
outside the department. All these interventions prescribed to patients the participants 
were consistent with literature studies by Zelle et al., (2012) as well as Guo, Tan, Li et 
al., (2013). In Table 1, some of the interventions suggested by Zelle et al., (2012) were 
supportive care and psychosocial care. Guo et al., (2013) also mentioned medication to 
patients who were undergoing several levels of anxiety and depression.  
Feedback from patients according to participants were mostly generally positive 
except in few instances. According to participants, patients get better and are less 
apprehensive to their treatment. Some of the participants indicated that some come with 
smiles on their subsequent visit and are more cheerful, friendly and open-up to talk more. 
Another negative comment from patients as reported by the participants was feeling 
fatigued after treatment, and more apprehensive after explanations. According to this 
study, patients become less anxious when they know what is wrong with them, how 
treatment will be delivered when proper explanations on the side effects is given and the 
more importantly what to do as and when an issue arises. The level of anxiety 
experienced by one patient with breast cancer may, however, differ from another patient 
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and that may probably explain why others had negative feedback. This finding was 
consistent with a literature study by Mura et al., (2012) that indicated reports of pain, 
weakness, and more apprehensiveness after patients received explanations for treatments. 
Management of Anxiety and Depression 
The interactions with participants ended with the way forward for patients, and 
this focused on the management of anxiety and depression for patients undergoing breast 
cancer treatment. The interventions were mentioned as management were the need for 
psychologists, spiritual, pharmacological, and physical. 
Psychologists. Almost all the participants indicated the urgent need of 
psychotherapist which will mediate as a counselor for the patients and the Oncology unit. 
There was a cognitive behavioral therapist who in a way falls under psychology. This 
result is consistent with findings discussed in the literature, such as ADAA, (2016). 
Again, management of anxiety and depression psychologically offer some benefit to 
patients on treatment. A psychotherapist of a behavioral therapist can assist patients by 
decreasing the distress associated with disease, thereby improving the quality of life 
through continuous counseling (Jacobsen & Jim, 2008). The oncology department will 
need this services even if on a part-time basis. The involvement of a psychologist could 
help reduce depression and anxiety with the study center. The study of Jacobsen & Jim, 
(2008) recommended some psychosocial evidenced-based interventions for the 
management of anxiety and depression. The researcher is buttressing on some of them 
that will be applicable in Ghana for staff and patients. These are relaxation techniques 
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with or without educational training, psycho-education, couples counseling for married 
patients, supportive expression therapy as well as cognitive-behavioral therapy. 
Relaxation techniques. This method helps patients to relax, attaining a state of 
calmness, thereby reducing anxiety or depression. 
Psycho-education. This is an evidenced-based therapeutic intervention where 
information and support in the form of education are provided to patients to help them 
understand and cope with their disease. 
Couples counseling. This is a form of helping the couples recognize and accept 
the situation at hand, and improving their relationship in the way of supporting each 
through the trajectory. 
Supportive expression therapy. This is a short term psychodynamic treatment 
aimed at a variety of diseases such as depression, anxiety and much more. The goal of 
this treatment is to underpin the patient’s healthy and adaptive patterns of thought 
behaviors, thereby reducing the effect on the body. 
Cognitive-behavioral therapy. It is a goal-oriented psychotherapy treatment that 
looks at the practical approach to managing problems through the change pattern of 
thinking or behavior. 
Spiritual. Two of the participants (33.3%) mentioned prayers as management, 
and surprisingly they were all nurses. According to Stranahan (2001), nursing is the 
ability to make someone feel physically comfortable by various means. Maddox (2001), 
also explained it as the capacity to develop the body's ability to achieve or maintain 
health. The perception on the ground is that patients are usually more comfortable talking 
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to nurses within the practice than any other profession, which may have perhaps led to 
this. A study by Oh & Kim (2014), concluded that spirituality is related to improved 
quality of life, and as well reduce anxiety and depression in patients undergoing 
treatment. According to them, spiritual interventions confirmed significant statistical 
effects on depression in patients with cancer.  
Physical Therapy. One doctor and a therapist mentioned the need for exercise as 
a form of management of anxiety and depression for patients undergoing treatment, this 
according to one of the doctors (D2) could help the get some relief. The finding was 
consistent with the study by Stewart & Wild (2016) that mentioned exercise as a benefit 
in helping reduce depression and anxiety in cancer patients. Danielsson et al., (2013) also 
suggested exercise as a way of improving depressive symptoms.  
Pharmacological. Among all the participants, only one (D1) cited prescription of 
medication to patients. This result was not out of order for a place like the study site 
because, in Ghana, only doctors are allowed by law to prescribe medicines to patients. 
This finding probably explains why no other person apart from a physician mentioned the 
need for medication. Medications according to Farach et al., (2012), could be used for the 
management of depression and anxiety, though the study concluded that the effectiveness 
and duration of treatment have not improved in most cases. According to studies by Pirl, 
(2004), there are 13 randomized controlled trials of medications of depressive symptoms 
for cancer patients including breast. Out of this, eleven are for primary treatment on 
depressive symptoms; only one was a pain symptoms, all the rest were for prevention. 
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From all indication, this will not be enough for cancer in general, looking at the various 
types of cancer worldwide. 
Interpretation of the Survey 
In research question 2, the investigator looked at how the effect of breast cancer, 
cost and waiting time affected patient’s responses to treatment as well as their anxiety 
and depression level. There were evaluations of the demographic variables such as 
marital status, age, education, ethnicity, among others in multivariate models (Table 3). A 
survey of 100 patient respondents between the ages of 20 and 89 years completed and 
returned the questionnaire. Eighty Nine percent had no family history of breast, and 43% 
were between the 71-90kg of weight. Though 51% of the patients were working full time, 
it did not reflect their salary or money earned in a month because 41% indicated NIL for 
monthly, perhaps were retired, student and unemployed (36%, 3%, 3%). 
With the family history, 89% had no history of breast cancer though diagnosed 
with the disease at the time of the study. This was consistent with studies as reported by 
ACS, (2013). According to ACS, between 5-10% of all breast cancer is inherited from 
parents and family members. Other studies also mention that women with close relatives 
to breast cancer patients have a higher risk of developing breast cancer (Shiyanbola, 
Arao, Miglioretti, et al., 2017). Another factor that doubles the risk of getting breast 
cancer is having one first-degree female relative such as mother, sister or daughter (Ja 
Kim, Jung, Eliassen, Chen, Willett, & Cho, 2017). In some instances, breast cancer is 
linked to having an abnormal gene such as BRCA 1, BRCA 2 and CHEK 2 (Ahern, 
Sprague, Bissell, et al., 2017). 
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The result highlighted 37% of the patients as Akan, followed by the GA’s (29%). 
The Akan population is the largest in Ghana comprising of the Fante, Asante, Akuapem, 
Akwamu, and Akyem, Agona, Kwahu, Wassa, and Bono. This results, therefore, explains 
the high percentage by the Akans. From the study of Montazeri, Jarvandi, Haghighat, et 
al., (2000), a patient usually show a different need for support with various ethnic 
background. This results could, however, be generalized to the overall breast cancer 
patients population who present for treatment in Ghana.  
With the majority of the patient (79%) within weight of 51-90 kg, it was 
indicative that most of the patients undergoing treatment were not overweight, nor obese. 
Usually, managing overweight and obese patients with breast cancer could be very 
challenging, in particular with the treatment technique of tangential fields. The treatment 
of breast which is usually tangential is to avoid treating the lungs and the heart within the 
chest region. However, with the tangential fields, the challenge with obese patients is the 
treatment of more breast folds within the axilla. According to the CDC reports in 2014, 
about 69% of all American adults are overweight, and this increases the risk of women in 
that category after menopause of developing breast cancer. The female hormone called 
estrogen usually support the growth of breast cancer. This estrogen often comes from 
fatty tissues, especially after menopause. Hence, an increased estrogen level enhances the 
chance of getting breast cancer. By implication, Ghana is slightly lower compared to 
some developed countries like America, to the risk of developing of developing breast 
cancer.  
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The link between weight and breast cancer risk which will result in anxiety and 
depression in patients is usually intricate. Studies have shown that risk increases for 
women who gain weight as an adult even though the same risk may not increase among 
those who have been overweight since childhood (American Cancer Society (ACS), 
2014). Though established that gaining overweight and obesity increases one’s risk, there 
is no clear indication whether losing weight reduces a risk. In Ghana, a culture like the 
Akan, frown on overweight and obesity though results showed more patients with breast 
cancer as Akan (Table 3). There are also some cultures in Ghana like the GA-
ADANGBE that see overweight and obesity as healthy living and evidence of wealthy 
living. In a study by Teras, (2012), the central question was whether overweight causes 
breast cancer. The author further indicated that women who lost weight and maintained it 
for over four years after menopause had a 40% lower risk of breast cancer.  
Reports from both the World Cancer Research and the International Agency for 
Research on Cancer Fund indicate that there is a substantial indication that being obese or 
overweight causes breast cancer after menopause. Another study, by the ACS, 2014, 
found out that loss of weight was associated with about 83% lower risk of breast cancer. 
It is therefore essential that patient with overweight and obesity tries to lose weight as 
much as possible to improve their overall health (Teras, 2012). Although the relationship 
between breast cancer risk and weight loss is still under investigation, one of the key 
factor is that women can control that body weight. 
In the study, 73% of the patient participants were married, and 11% were 
widowed (Table 6). According to the results, 83% were indicated their anxiety and 
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depression with treatment (Table 7). In a study by Vahdaninia, Omidvari, & Montazeri, 
(2010), it was identified that being single was a protective factor for developing 
psychological distress while the widowed showed a greater risk. This findings was 
however not the case in this study because 83% of the patient population indicated levels 
of anxiety and depression though 73% of them were married. Again, marital status was 
associated with quality of life in a study by Parker, Baile, Moor, & Cohen, (2003) and 
patients with more family support reported less anxiety and depression. Contrary to the 
findings of Parker, et al., (2003), Hassan et al., (2015) was of the view that married 
women go through many levels of anxiety and depression because of family life and 
other dependents to take care. Again, Hassan was of view that single women may be 
scared of losing their partners and friends due to their loss of femininity attraction. 
The disease duration shown in Table 3, revealed that only 13% of the participants 
presented within a year, but 55% were between the 1-3 years. This finding confirms late 
presentation of breast cancer in Ghana as reported by several studies (Opoku et al., 2012; 
Anderson et al., 2011; Clegg-Lamptey & Hodasi, 2007). Although the study did not find 
out reasons for late reporting on the side of the patients, the average duration of 
symptoms of more than a year is disturbing. This finding is similar to what was reported 
from the same hospital five years ago, indicating no effect of breast awareness programs 
because of the patient resort to herbal medications (Clegg-Lamptey & Hodasi, 2007). 
Most of the patients who presented after three years had probably reported previous and 
defaulted, likely to try an alternative treatment. 
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Anxiety and Depression in Daily Life of Patients.  
Almost 95% of patients with breast cancer had anxiety and depression in different 
categories ranging from occasionally, quite and very often (Table 6). This result is very 
high compared to studies conducted Baqutayan, (2012) and Hassan et al., (2015). There 
can be some reasons for this differences in prevalence rate. The first explanation could be 
the late stage of presentation, the high cost of treatment, lack of financial support, lack of 
NHIS, inadequate family support, family dejections, ignoring by spouses, separation, 
divorce, fear, and the fact that some think it is communicable. There are other factors like 
the way of presentation of breast cancer in the African context, such as witchcraft, juju, 
and curse. Others resort to prayer camps, and there is various misinformation by spiritual 
leaders which leads to delay in presentation and then causes depression upon treatment. 
There is a link between late presentation of breast cancer and awareness creation 
of the disease. In a study conducted by Clegg-Lamptey & Hodasi, (2007) about 60% of 
the breast cancer patients in Ghana reported with Stage III and IV disease within a 
duration of 8 to 10 months. This finding, according to Brewster, Thomson, Hole, Black, 
Stroner, & Gillis, (2001) is similar to the presentations within the developing countries 
and in Black American women. In Ghana, the duration between the detection of a breast 
cancer and presentation of clients to a hospital for treatment is usually long, and this was 
consistent with the findings of this study. Delay in treatment is common within the 
African context due to several reasons. 
The term delay was defined by Harirchi, Ghaemmaghami, Karbakhsh, Moghimi, 
& Mazaherie, (2005) as the duration (two weeks or more) before visiting the hospital. 
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Other studies by Arndt, Sturmer, Stegmaier, Ziegler, Dhom, & Brenner, (2002) defined 
delay as the duration between a month to three between symptom recognition and 
seeking treatment. In contrast, Stapleton, Mullan, Dey, et al., (2011) was of the view that 
delay deals with the stage of the disease presentation. 
Therefore, addressing the causes of this delayed presentation is probably essential 
than the promotion of early detection within the country. Usually, the worry is not only 
late presentation by patients, but also absconding of breast cancer treatment. Studies 
show that within the study site, almost 13% of breast cancer patients abscond after 
treatment has commenced (Clegg-Lamptey, Dakubo, & Attobra, 2009). The effect of this 
is more advanced stages, inoperable and incurable after these absconders later return.  
Reasons for late reporting by patients according to studies were the lack of 
specialist within the country, ignorance on the side of patients, fear of mastectomy 
(Clegg-Lamptey et al., 2009; Elmore, Armstrong, Lehman, & Fletcher, 2005). Others 
reasons from the studies were herbal treatment, prayers and prayer camps, financial 
incapacity on the side of the patients, the fear of diagnosis, and resorting to food 
supplement by patients. Other reasons for absconding treatment by patients were fear of 
mastectomy, side effects of the chemotherapy, faith in their God among others.  
Screening for breast cancer has, however, lead to an early diagnosis of breast 
cancer and a reduction in mortality among patients (Elmore et al., 2005). In Ghana, no 
organized nationwide screening program involves mammography to women at risk of 
breast cancer. Although some non-governmental organizations (NGOs), individual 
survivals, and other well-meaning groups try to organize breast cancer awareness 
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seminars, talks, and conferences to educate women in this regard (Clegg-Lamptey et al., 
2009). Though programs to stimulate early detection may not yield much of the desired 
goal because of the human resource available currently, it is essential to realizing early 
diagnosis in Ghana to help curb late presentations. In the developed countries many 
breast cancers are recognized by the patients, and that helps with early presentation. 
Hence, education of what to look out for and self-breast examination will also be crucial 
in helping avoid late presentation (DeSantis, Ma, Bryan, & Jemal, 2014). When diagnosis 
is made, education for patients could significantly reduce patients’ level of anxiety and 
depression. 
Fear as defined in a study by Donkor, Lathlean, Wiafe, Vanderpuye, Fenlon, 
Yarney, & Kyei, (2016) is an inimitable expressive state of a person which is a prompt 
response to a danger or any threat. According to Abdel-Wahab, Bourque, Pynda et al., 
(2013), fear is described by the wish to escape. In most developing countries, the disease 
is characterized by fear due to the nature of the disease, mortality rate, and the attribute 
that is witchcraft and death. The diagnosis of breast cancer, therefore, trigger different 
forms of fear, affecting the presentation of treatment and leads to anxiety and depression 
even when they present in Ghana. The possible reason is the fact that breast cancer 
education, survivor and support groups barely exist. Again, awareness creation is not 
universal, and breast survivals fail to come out publicly and share their experience for 
fear of mortification as well as stigmatizations. 
Several studies have recognized the use of alternative medicine as a reason for the 
delay of breast cancer patients, and late presentation which in effect leads to anxiety and 
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depression (Ermiah, Abdalla, Buhmeida, Larbesh, Pyrhönen, & Collan, 2012; Ibrahim, & 
Oludara, 2012; Otieno, Micheni, Kimende, & Mutai, 2010 Ukwenya, Yusufu, Nmadu, 
Garba, & Ahmed, 2008). In the studies by Ermiah et al., (2012) and Otieno et al., (2012) 
the two categories of alternative medicine that were identified to be common within the 
African context, where the locally based and foreign based therapies. Local based 
comprised of spiritual, prayer, traditional healer as well as herbal treatment. That of the 
external support were acupuncture, homoeopathy, and Chinese medicine. 
Donkor et al., (2016) explains that the personal belief of patients was highly 
related to their using alternative medicine and therefore, the cultural model of every 
patient was essential. According to Stephens, Fryberg, & Markus, (2012), the cultural 
model any disease is defined as the cognitive model which postulates that seeking health 
care is prejudiced by cultural perceptions of the cause of that disease, the management as 
well as the coping behavior to eradicate the disease. In Africa, and Ghana, in particular, 
many cultures associate cancer with mystical beliefs and symptoms of disease are 
ascribed to a curse, bewitching, God or god’s punishment due to personal or family 
atrocity or demons. These cultures can be very demoralizing to patients causing severe 
anxiety and depression on patients (Opoku et al., 2012). Their belief in the line of this 
makes it difficult to manage with contemporary medicine such as such as surgery, 
chemotherapy or/and radiotherapy will only worsen the condition. As a result of these, 
many Ghanaians rely on their faith, sorcerers, witch doctors, herbalists, 
priests/priestesses, pastors, and other spiritualists to treat cancer.  
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Anxiety and Depression of Patients on Treatment.  
In this study, out of the 1, 797 responses from patients about 83% of them had 
depression and anxiety in different categories ranging from occasionally, quite and very 
often (Table 7). In Table 8B, the F value was 0.058, which indicated that the null 
hypothesis could be rejected and the alternate accepted. In this case, the conclusion is that 
there is a significant relationship between the responses of breast cancer patients and their 
level of anxiety and depression as well as treatment responses. The finding was consistent 
with other studies in Iran that showed 47.2%, and 57% of anxiety and depression 
respectively, though the percentage is very high in Ghana (Jadoon et al., 2010). Other 
studies in Pakistan also showed similar trends with 52%, 62% on anxiety and depression 
respectively (Jadoon et al., 2010). As explained earlier in the literature, the high 
prevalence of over 80% in Ghana could be patients’ fear of death in the course of 
treatment, loss of hair during treatment, and their inability to get pregnant after treatment. 
Interventions for Anxiety and Depression.  
According to the responses from the patients, in Figure 10, there is very little 
information on Cognitive Behavioral Therapist to help them cope with the treatment. As 
a result of this many of the responses indicated that patients resort to meditation and 
prayers for management. This findings has been discussed thoroughly earlier. Medication 
was also not seen as a regular form of management, though some patients mentioned it. 
However, physical therapy was indicated by 18.3% of the patients undergoing treatment. 
The findings were inconsistent with studies in the developed where interventions such as 
psychosocial and other interventional supports helped cancer patients in adjusting to their 
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diagnosis and treatment (Mustian, Alfano, Heckler, et al., 2017). An example was in a 
study by Guo et al., (2013) where psychosocial interventions supported patients by 
decreasing their psychological distress associated with cancer and improving their quality 
of life. Another study also indicated that Psychosocial and pharmacologic interventions 
offer some benefit on treatment for depressive symptoms with cancer patients (Baucom, 
Porter, Kirby, Gremore, & Keefe, 2006). 
Regarding prayer, when individuals are faced with difficulties, comprising severe 
and life-threatening conditions such as cancer, they turn towards a higher power or 
religion as a way of coping (Thune-Boyle, Stygall, Keshtgar, & Newman, 2006). There 
have been works on the effects of religious/spiritual coping in cancer and the differences 
in these studies are in terms of methodology, and stages of disease (Nia, Sharif, 
Goudarzian, Allen, Jamali, & Gorji, 2017; Lewis, Maltby, & Day, 2005; Abernethy, 
Chang, Seidlitz, Evinger, & Duberstein, 2002). However, the results consistently show 
the importance of religiosity and spirituality in coping with a cancer diagnosis. Some 
other studies have found religiosity and frequent religious attendance to be protective 
factors against cancer (Mytko & Knight, 1999).  
Other studies also highlighted the benefits of religious commitment which is 
affiliated with a particular church, rate of worship attendance as well as beliefs and 
concluded that these were associated with low level of anxiety (Ano & Vasconcelles, 
2005). There has also been a significant bearing of religious coping in cancer patients on 
quality of life, and this has received prodigious consideration suggesting improvements in 
the quality of life of individuals committing to religion to cope with cancer (Tarakeshwar, 
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Vanderwerker, Paulk, Pearce, Kasl, & Prigerson, 2006). Daaleman & Vandecreek, (2000) 
were of the view that coping with breast cancer religiously, provides a sense of drive and 
a context for the thoughtful experience of the disease even when it is advanced. 
Integration of Data 
This final stage of integration of quantitative and qualitative data through 
triangulation was used to understand further the entire literature and the findings of the 
staff and patients undergoing treatment. As was discussed in the methodology, the study 
used a combination of qualitative and quantitative data through a concurrent triangulation 
involving an interview with some selected professional participants and a detailed survey. 
The triangulation method was to show how the interviews support, confirms or 
disconfirm the responses from the patient participants.  
The interviews with the professionals did support the responses from the patient 
participants. This support were in three sections on the experiences of breast cancer 
patients undergoing and how it affected breast cancer patients undergoing treatment. The 
first was on the cost of treatment which was discussed thoroughly by the professionals. 
This cost on the treatment supported the several complaints of patients due to the high 
cost of treatment and their inability to pay treatment because of the kind of job they do. 
This same cost, in turn, led to anxiety and depression on the side of patients. The second 
was on the burden of disease discussed by the participants which covered a variety of 
issues including waiting times. The final section looked at the interventions and 
management where the professional participants discussed what they do for patients to 
cope with anxiety and depression such as prescription of medications, and referral to a 
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psychologist. Other interventions practiced in Ghana by many patients that did not show 
up clearly in the study within the oncology setting was physical therapy, and spiritual. 
The patient also discussed management though they mentioned meditation, and prayer as 
their highest form of managing anxiety and depression.   
Theoretical Framework and Research Findings 
The theoretical basis for this study buttressed the inputs provided in the survey 
that informs preventive or coping for patients undergoing anxiety and depression. This 
model was used to describe breast cancer treatment processes from the onset of the 
diagnosis, through treatment and the aftermath of treatment. The theory was again used to 
predict factors that lead to anxiety and depression both from patients and professionals. 
Finally, this theory was used to explain the management or coping with breast cancer 
within the context of the setting of the study. The findings of this study suggested a high 
level of anxiety and depression among breast cancer patients undergoing radiotherapy. 
The interventions mentioned by the patients showed less of cognitive behavioral 
therapists or psychologists, but the involvement of prayer, and meditation by the patients 
themselves.  
The framework HAPA outlined motivational and volitional concepts used in the 
explanation and the prediction of individual changes in health behaviors among breast 
cancer management. The self-value of patients undergoing treatment was essential in the 
responses they gave on their depression and anxiety level. The motivational phase which 
dealt with issues of the risk awareness of patients were in two sections. The first, looked 
into patients’ level of information about their diagnosis and the second was of their 
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responses. These two points were seen to have caused an increased in the anxiety and 
depression of patients undergoing treatment as reported by some of the professional 
participants. A concern to the researcher was the effect would occur on their level of 
survival and cope with treatment. 
In the volitional stage, an intention to change a health behavior was needed, and 
such change as discussed with both patients and staff participants in the results sections 
was the need to strengthen the interventions necessary for these coping process. This 
intervention according to Schwarzer, (2008) must be planned, introduced, and sustained 
within the oncology setting, and as well, making plans to adjust, manage and 
accommodate any relapses that may occur during the process.  
Limitations of the Study 
One of the limitations among the issues identified was the recruitment of patient’s 
participants for the quantitative study. Some of these patients were undergoing chemo-
radiation and therefore required that the researcher include them in the study. This did not 
allow data collection only patients undergoing radiation treatment. The researcher 
however, recruited patients directly from the treatment floor, where the participants start 
the treatment.  
Another limitation of the study which was discussed in the introduction was the 
language barrier since not all the members spoke, read or wrote in English. Although, 
plans were put in place for translation into the local language where the need arose, there 
was no systematic means to determine if the patient participants were in any way 
influenced by the investigator. 
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Additionally, the timeframe of when participants' answered the questionnaires, 
was not under the control of the researcher although an average time of 15 minutes was 
allocated for this. This may have influenced the responses from both the professionals 
and patients as several conditions could result in the description for the results/responses 
obtained. 
Finally, since the study was limited to data on patient’s socio-demographics level 
of anxiety and depression, other potential concepts of perceived anxiety and depression 
such as diagnosis, prior mental issues, and patients’ medications were not reconnoitered. 
Unknown is whether, these variable constructs could have affected the study if explored.  
Implication for Social Change 
This study is imperious to promoting the scholarly research concerning the 
complete translation of the coping strategies in handling anxiety and depression. It is, 
therefore, crucial to improving on these numerous interventions and strategies that 
manage or cope with anxiety and depression, afore, through and after treatment. These 
supports will assist patients to deal with issues that confront them when undergoing 
treatment. Professionals have discussed thoroughly the issues confronting patients, and in 
turn, patients have voiced out their burden as they go through treatment. The researcher 
has outlined suggestions and coping mechanisms as a way of solutions throughout the 
discussion. The effect of the applications of these approbations will result in a social 
change from the study.  
On the side of the professionals, it is essential that every multidisciplinary team 
member within the Oncology team ensures that efforts are put in place to identify and 
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capture the coping mechanisms of every individual patient. Having in mind that every 
patient should be treated in a particular way because they cope differently with the 
burden of breast cancer, will help put in place support systems to assist, and inspire them. 
Again, there should be motivation for patients in helping them to develop coping skills 
needed to bear the psychological, financial, emotional, and the physical pain of the 
treatment. 
Family members could be a source of strength to patients serving to improve the 
survival of patients even with the late diagnosis. Relatives and loved ones can be of help 
in assisting patients to discover working strategies to cope or manage their depression 
and anxiety. Reassurance, showing of affection, care and expression of concern for these 
patients will help them meet these burdens from the treatment, and their respective side 
effects. Again, educational supports could help patients who can read to a better deal and 
cope with the burden of the disease. Doctors and nurses should again bear in mind the 
possible addiction of drugs, and should cogitate non-pharmacological remedies to lessen 
the debilitating effects of this anxiety and depression (Koob, 2006). 
The study’s implications will contribute to wider society and cause positive 
change when all stakeholders (caregivers, multidisciplinary team, the ministry of health, 
Ghana health service, and the Government) take on responsibilities. These are helping, 
assisting, and putting in place measures that will guide the coping strategies of breast 
cancer patients. The information gained in this study will additionally help fill the gap in 
the literature on the assessment levels of depression and anxiety and how this assessment 
impact treatment outcome for breast cancer patients undergoing radiotherapy. 
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Recommendations 
Recommendations for Action 
For the useful implementation of the results, a summary will be disseminated to 
the three Oncology Centers in the country. This process will improve the knowledge of 
the breast cancer management and as well the coping mechanisms for patients in these 
categories. In doing this, the overall team members involved in the disease management 
will be more observant, vigilant and open to proceed with the suitable interventions and 
referrals as and when needed. A summary of these findings will also be available in 
written form, available in English and Twi, for patients with the contact details of the 
investigator in case they may have any questions. Each patient participant contributed to 
the study, and therefore these feedback regarding the results is necessary.  
One recommendation which is keen will be for the Government and the Ministry 
of Health to place breast cancer treatment (Surgery, Chemotherapy, and Radiotherapy) on 
the NHIS. This request will be a significant relief for patients and family and will in 
effect cause patients to report early to the hospital. It will also help caregivers appreciate 
the survival of their patients on treatment and improve satisfaction to work. Another 
recommendation is getting free mandatory breast cancer screening services for patients in 
Ghana. This will also help see patients early and improve survival of patients. Finally, 
there are few oncology practitioners (30) in Ghana managing all cancer cases across the 
length and breadth of the nation. I recommend the training of more staff, or possibly 
sponsor more people who will show interest but have no financial support to undergo this 
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program. This training in effect will improve patient-to-staff ratio and overall affect the 
care given to patients. 
Recommendations for Further Study 
The study confirmed higher levels of anxiety and depression among breast cancer 
patients undergoing radiotherapy treatment. Treatment of most of the breast cancers seen 
in Ghana requires radiotherapy, and the reason for this is the late presentation. Surgery 
and chemotherapy served as an adjuvant treatment before the commencement of the 
radiotherapy. The predictive relationship between late presentation and anxiety and 
depression were due to the factors such as cost, alternate medicine, and spirituality. 
Further studies with a larger population on late presentation of breast cancer covering the 
three cancer units in the country are recommended to provide an additional overview the 
situation in Ghana.  
Again, further study to involve anxiety and depression of breast cancer patients 
from the surgery would provide support for this study's findings. Additional research may 
consider broadening the risk factors of the demographics to include the medical 
conditions before the presentation, medications history, stage of presentation would 
provide support for the findings. Lastly, future research may embrace investigation of the 
various risk factors associated with the separate items on depression and anxiety. There 
were several indications of depression which were distinct from anxiety, and that could 
additionally support the study’s findings.  
104 
 
 
Concluding Statements 
There is a significant relationship between the responses of breast cancer patients 
undergoing radiotherapy and their level of anxiety and depression. Patients undergoing 
breast cancer treatment go through several experiences such as the burden of the 
treatment, high cost of treatment, and waiting time, resulting in high-level anxiety and 
depression. Late presentation to treatment is common in Ghana as a consequence of the 
multiplicity of reasons, affecting the overall survival of breast cancer patients. The effect 
sizes of the selected participants show a strength of relationship though not every variable 
was statistically significant to patients’ level of anxiety and depression. Further and 
future research with a larger sample size of patients from all the three Oncology 
departments within the country would shed more light on the relationships examined in 
this study.  
The study illustrates a need to understand how breast cancer patients in Ghana go 
through treatment with the high impact of anxiety and depression with treatment which 
affects total well-being and life after treatment. A further study using other cancers may 
allow the multidisciplinary team to envisage how interventions could be put in place to 
help entire patients cope with the disease. The success of these projections will eventually 
improve patient care and the delivery of health care in Ghana. A soon as the study is 
instigated, social change will have a budding realization rate. 
Although interventions and management should be available to breast cancer 
patients with anxiety and depression undergoing treatment for their coping with the 
burden of the disease, a striking improvement in the survival of patients could be 
105 
 
 
achieved when proper systems are put in place by the Ministry of Health and the 
Government.  
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Appendix A: Survey Instruments 
WALDEN UNIVERSITY 
COLLEGE OF HEALTH SCIENCES 
SCHOOL OF PUBLIC HEALTH 
 
Title: Assessment of Anxiety and Depression among Breast Cancer patients in Ghana 
Name of Researcher:  
Name of Supervisors:  
 
 
Please remember that this is not a test and there no answer regarded as correct or wrong. 
Individual participants may have different responses and no one will know how you 
answered the questions. 
 
If you have any concern about the study and you wish to contact someone independent, 
you may contact: 
 
 
 
Instructions: Please tick or insert the appropriate feedback 
 
Part One: Socio-Demographic Data 
1. Folder Number……………………………        
2. Age ………………………………………. 
3. Weight…………………………………… 
4. Gender: Male     [    ]       Female  [    ] 
5. Tribe……………………………………… 
6. Marital Status: Single [   ]  Married [   ] Divorced [   ]  Widowed [   ]  
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7. Current occupation or last job……………………………………….. 
8. Current Employment status: Full time [   ]  Part time [   ]  Unemployed [   ] Retired [   
] Student [   ] 
9. Total monthly income  ………………………..GH Cedis 
10. Disease Duration:   Less than 1 year [   ]  Between 1 and 3 years [  ] Greater than  3 
years [  ] 
11. Family History: Yes [   ]   No [   ] 
 
Part 2A: Anxiety and Depression about your Treatment 
  
1. I feel tense  about my treatment 
 Not at all [   ]    Occasionally [   ]   Quite often [   ]   Very often [   ] 
2. I get frightened when I have to go for my treatment  
Not at all [   ]     Occasionally [   ]   Quite often [   ]   Very often [   ] 
3. The duration of treatment makes me nervous  
Not at all [   ]     Occasionally [   ]   Quite often [   ]   Very often [   ] 
4. The waiting time makes me more anxious 
Not at all [   ]     Occasionally [   ]   Quite often [   ]   Very often [   ] 
5. I am losing interest in my appearance during my treatment 
Not at all [   ]     Occasionally [   ]   Quite often [   ]   Very often [   ] 
6. I feel restless anytime I have to wait for my turn in treatment  
Not at all [   ]     Occasionally [   ]   Quite often [   ]   Very often [   ] 
7. I do laugh and see the funny side of things during my treatment 
Not at all [   ]     Occasionally [   ]   Quite often [   ]   Very often [   ] 
8. There is a worrying thoughts anytime I have to go for my treatment  
Not at all [   ]     Occasionally [   ]   Quite often [   ]   Very often [   ] 
9.   I get sudden feelings of panic 
Not at all [   ]     Occasionally [   ]   Quite often [   ]   Very often [   ] 
 
Part 2B: Anxiety and Depression about Life during Treatment 
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1. Since the diagnosis, I am able to concentrate on what I do 
 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
2. I have loss of sleep over worry 
  
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
3. I am capable of making decisions after diagnosis was made 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
4. I feel constantly under strain  
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
5. I am able to enjoy day-to-day activities 
 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
6. I feel unhappy and depressed  
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
7. I have lost confidence after the diagnosis 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
8. I now thinking of myself as worthless  
 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
9. I have little interest or pleasure in doing things  
 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
10. I feel down, depressed or hopeless 
 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
11. I feel bad about myself 
 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
12. I feel I have let my family down  
 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
13. I have trouble falling or staying asleep 
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Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
14. I sleep too much 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
15. I feel tired and have little energy 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
16. I have poor appetite 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
17. I have troubles with concentration  
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
18. I have strange thoughts that I am better off dead than alive 
Not at all [  ] Several Days [  ] More than half the days [  ] Nearly every day [  ] 
 
Part 3: Interventions of Anxiety and Depression 
 
1. My doctor has referred me to a Cognitive-behavioral therapy (CBT) for counselling 
          Yes [   ]   No [   ] 
2. My Therapist has advised me to exercise when I feel anxious or depressed 
          Yes [   ]   No [   ] 
3. Whenever I feel depressed or anxious, I meditate 
          Yes [   ]   No [   ] 
4. Whenever I am anxious or depressed, I pray 
    Yes [   ]   No [   ] 
5. My doctor/Nurse have advised that I take my medication when I feel nervous or 
depressed 
    Yes [   ]   No [   ] 
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Appendix B: Letter of Invitation for Professionals 
Title of Study: Assessment of Anxiety and Depression among Breast Cancer patients in 
Ghana 
Name of Researcher: Kofi Adesi Kyei 
Name of Supervisors:  
 
I, Kofi Adesi Kyei, from the Department of Public Health, Walden University, invite you 
to participate in a research project entitled Assessment of Anxiety and Depression among 
Breast Cancer patients in Ghana. 
The purpose of this research study aims to find various interventions for depression and 
anxiety among breast cancer patients in Ghana. Should you choose to participate, you 
will be interviewed briefly to share and provide different opinions about anxiety and 
depression of the breast cancer patients under your care as they go through radiotherapy. 
The expected duration for this interview will be 15 minutes 
Through this the study, the quality of life of breast cancer patients undergoing 
radiotherapy could improve particularly during their end-of-life stage. The expectation is 
that the study will promote positive social change in the form of coping strategies, and 
awareness creation, with the aim of preventing breast cancer. The latter will be through 
various levels of cancer education to both the client and the caregivers. Findings from the 
study could also be used to plan policies that may support methods beneficial to the 
advancement of Oncological services within Ghana and Africa since many neighboring 
countries within the West Africa patronize the Oncology services in Ghana. Finally, the 
135 
 
 
possibly positive social change resulting from the study could be seen globally and 
locally providing a basis for future studies, especially within the cancer setting within the 
coming years on depression and anxiety. 
At the end of the interview you will be contacted to review the transcript. 
If you have any pertinent questions about your rights as a research participant, please 
contact   
 
 
 
Thank you, 
 
Investigator’s Signature      ………………………… 
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Appendix C: Semi structured Interview Questions  
E 1: Semi-structured interview questions with the Oncologists 
Researcher’s questions 
1. In your clinical reviews, do you get complains from patients about their level of 
depression and anxiety? 
2. What form of interventions do you prescribe for these patients? 
3. Do you get any positive feedback as responses from these patients during next 
visit or follow-up? 
4. In your opinion, what can be done to improve the management of depression and 
anxiety of breast cancer patients? 
5. Can you share your experience with me, how you have used your method of 
intervention to manage the anxiety and depression of breast cancer patients 
undergoing treatment 
 
E2: Semi-structured interview questions with the Radiotherapists 
Researcher’s questions 
1. In your daily treatment, do you get complains from patients on the level of 
depression and anxiety? 
2. What forms of interventions do you discuss with them? 
3. Are there any feedback you receive from these clients? 
4. Do you think the team can improve the management of anxiety and depression of 
breast cancer patients? 
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5. Is there anything, you will like to share with me on your experiences with 
patients. Are there any peculiar interventions you have used in the past? 
E3: Semi-structured interview questions with the Nurses 
Researcher’s questions 
1. In your weekly reviews, do you get complains from patients on the level of 
depression and anxiety? 
2. What forms of interventions do you discuss with them? 
3. Are there any feedback you receive from the patients? 
4. Do you think your team can improve the management of anxiety and depression 
of breast cancer patients? 
5. Is there anything, you will like to share with me on your experiences with 
patients. Are there any peculiar interventions you have used in the past? 
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Appendix D: Letter of Cooperation 
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Appendix E: Interview with D1 
Interview with Doctor Asamoah on the 4th July 2017. Asamoah is a Radiation Oncologist at the Oncology 
Department of the Korle-Bu Teaching Hospital. He lives in Accra Ghana and has practiced for over Five 
years 
 
Q.1. Complaints from Patients 
 
Kofi 
In your daily treatment, do you get complains from patients about their level of depression and anxiety? 
 
Asamoah 
Yes, we do normally on their weekly reviews, when the patients come in for review, some of them will not 
normally speak out until you ask them. But you can tell from their body language that they are depress and 
anxious about the ongoing treatment.  
Sometimes, I can tell from their faces and further probe into it by asking them. Some of them open up 
especially their treatment, having little idea about and on the treatment whiles others are worried about the 
side effect of the therapy.  
I also can tell from the level of questions they ask me in the consulting room. It tells how anxious and 
depressed they are. Some ask questions about the aftermath of treatment and what will happen to them. 
Whether the treatment will be effective at the end or not. 
 
Q.2. Interventions prescribed 
 
Kofi 
What forms of advice and interventions do you prescribe for these patients?  
 
Asamoah 
Well, I think the clinic is always heavy for the breast cases and so we spend less time with patients. But 
personally, I try to reassure them of the treatment and counsel them of the fact that the side effect are not 
permanent and that once they finish their treatment it will end. Sometimes, I also prescribe some 
medications to take care of the anxiety, and depression, some even get sleeping tablets because their sleep 
is impaired. 
Mostly,  I think that the reassurance I give sustain them throughout their treatment. 
 
Kofi 
Let me pick up on what you said about the less informed patients. Where is that coming from, because we 
know you doctors do the counselling? 
 
Asamoah 
You can identify a lot of areas, I wouldn’t say the clinic alone, but they also go through treatment every day 
of the week, and some also go through chemotherapy. But mostly I think because the first point of call is 
the doctors, they may have to bear that. I think we need to have more time for the patients in the clinic. 
Some of the patients will also leave the clinic without any information because of the same anxiety and 
depression. They will now present it as if we didn’t explain anything to them. Some of the patients also try 
to do double check on the information received, hence will pretend that they have not been informed. 
I think studies have even showed that financial burden of patients affect the informations they receive in the 
clinic. I think to me its multi-factorial. 
 
Q.3. Feedback from patients  
 
Kofi 
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Do you get any positive feedback as responses from patients during their next visit of follow-ups?  
 
 
Asamoah 
Yes patients usually get better and are less apprehensive in their next visit. Our reviews are weekly and so 
by the next visit, the patients will have undergone five sessions of radiotherapy and usually, they are better, 
some even will have smiles on their faces and others will also want to ask more questions. 
 
Q.4. Management 
 
Kofi  
In your opinion, what can be done to improve the management of the depression and anxiety of breast 
cancer patients? 
 
Asamoah 
Doctors and the other staff can really improve on the discussion and counselling session with patients. I 
think patients need more time, though we are trying, more time for them could improve their management. 
I also think that oncology department needs a clinical psychologist, it’s very important because they can see 
to these patients separately.  
 
Q.5. Share your experience 
 
Kofi 
Can you share your experience with me, how you have used your method of interventions described to 
manage the anxiety and depression of patients undergoing treatment. 
 
Asamoah 
There was one particular patients I saw in clinic who was concern about the darkening of her skin as a 
result to radiation, sore throats and her ability to go back to work after treatment during my counselling 
session. She was anxious of the outcome and as well depressed about the post treatment, family life and 
coping with work. 
What I personally did was to ask of her from the therapist on daily basis, spend more time with her during 
review and counselling. Kept reassuring her o weekly basis through to her final day. I created a friendly 
environment whenever I saw her at the clinic and that made her feel more relax to face the reality. 
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Appendix F: Interview with D2 
Interview with Doctor Ntiamoah on the 30th June 2017. Ntiamoah is a Radiation Oncologist at the 
Oncology Department of the Korle-Bu Teaching Hospital. He lives in Accra Ghana and has practiced for 5 
years 
 
Q.1. Complaints from Patients 
 
Kofi 
In your clinical reviews, do you get complains from patients about their level of depression and anxiety? 
 
Ntiamoah 
I will want to start from the from the simulation process, because we review them prior to simulation and 
treatment. The simulation procedure requires that the women remove their cloths, before the process could 
begin. You and I know how women cherish their breast, hence that alone makes them depressed and 
anxious. Remembers that it begins the whole process, and if they are to daily remove their dress for 
treatment, it certainly not a pleasant situation. 
We in the clinic try to explain to them the whole process, but I think that not until they get through the 
simulation, they will not see how hard it will be. These are some of the complaints patients go through. 
Exposing themselves especially to male therapist is a big issue for these women. Mind you therapist in 
Ghana are highly dominated by males, about 4:1 ratio. 
Patients also complain about their skin marks made on their body by the therapists as a way of keeping the 
treatment field. These marks according to the patients do itch, makes the anxious and sometimes form 
blisters. According to these, most of the time, they are not informed about the side effects of the skin marks 
and this makes them very uncomfortable even at home. This makes them more anxious. 
Patients also complain of financial burden as they have to pay their treatment from the beginning through to 
the end. That indeed is a mind blowing and affects their level of anxiety and makes them depressed. Most 
of them say they are traders and earn very little and therefore the bill of payment is an issue for them. 
 
Kofi 
OK, what about those on treatments?  
 
Ntiamoah 
The most complains patients talk about with me is the darkening of their skin, sore throats, and fear of 
death resulting from the conversations they have with other friends, relatives and other patients. Some of 
the things they hear according to these patients make them more anxious and depressed and it’s even scary. 
 
Q.2. Interventions prescribed 
 
Kofi 
What forms of advice and interventions do you prescribe for these patients?  
 
Ntiamoah 
Yes, myself for instance, I try to educate them on the disease and the entire procedure through simulation 
and treatment. I try to assure them of the treatment and encourage them to go through to the end. What I 
think it’s the issue is that the patients’ complaints indelible marks we put on the patients is too much and 
that makes and increases their anxiety level.  
With the treatment, I keep assuring them and give them the right informations. If one is not sure of any 
interventions should refer to the appropriate unit. 
 
Q.3. Feedback from patients  
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Kofi 
Do you get any positive feedback as responses from patients during their next visit of follow-ups?  
 
Ntiamoah 
Patients think a lot from variety of issues but besides, from their next visit or review, most of them have 
become better and their confession changes. The anxiety may not be completely gone, neither the 
depression, but they will still be positive. 
 
Q.4. Management 
 
Kofi  
In your opinion, what can be done to improve the management of the depression and anxiety of breast 
cancer patients? 
 
Ntiamoah 
I think that we need psychologists to handle these patients, you know the workload is much higher on the 
sides of the doctors, we are few, see patients in the clinic, do brachytherapy, chemotherapy, planning, etc, 
hence, it will not be enough for us to see all these patients on daily basis and have so much time for them 
because of the workload. Education on patients should be all round through the treatment. 
 
Q.5. Share your experience 
 
Kofi 
Can you share your experience with me, how you have used your method of interventions described to 
manage the anxiety and depression of patients undergoing treatment. 
Ntiamoah 
I can remember one of the patients I saw some few months ago, she came for review and I realized that she 
was disturbed and so I decided to talk to her. Money to pay bill was a problem, husband was not in talking 
terms with her because of the burden of the family, besides they got married not long ago. 
The disease was heavy on her and that made her depressed and so I kept talking to her from one review to 
the next and I think it did help her. 
  
143 
 
 
Appendix G: Interview with R1 
Interview with RTT Pearl on the 30th June 2017. Pearl is a Radiation Therapist at the Oncology 
Department of the Korle-Bu Teaching Hospital. She lives in Accra Ghana and have practiced for Five years 
 
Q.1. Complaints from Patients 
 
Kofi 
In your daily treatment, do you get complains from patients about their level of depression and anxiety? 
 
Pearl 
Yes, they do complain and usually the complaints on anxiety has to do with not knowing much about the 
treatment. Apart from this, some of them are illiterate, so explanations might have gone on by the doctors 
but by the time they get to the treatment, they may have forgotten everything. They may probably have 
misunderstood all what the doctors said and refused to asked questions because of the same anxiety. Again, 
just the fact that they have been diagnosed of cancer is enough to cause depression in them. 
Depression has to do with in the lay man’s term ‘the person’s spirit is really down’ or one’s spirit being 
dumping. But anxiety is worrying about the conditions and what is going to happen if I should explain 
further. So just seeing machines at the treatment unit is enough to scare them through their treatment 
trajectory. 
 
Q.2. Interventions prescribed 
 
Kofi 
What forms of advice and interventions do you prescribe for these patients?  
 
Pearl 
Sometimes this anxiety and depression stems from not knowing what the treatment is all about. So some of 
the interventions are explaining exactly what the process is all about, and letting them know that, yes the 
machine is big, and scary but this is what it does to treatment. You also have to inform them that you will 
be monitoring them on the machine in the control room, when they talk we can hear them and see them so 
they cause for fear.  
We also inform them that if they are in any form of distress, they should signal us and then we will come to 
their aid. We also assure them that they will get used to the treatment within a day or two, eventually they 
get used to it. 
Apart from that, we advise them on their waiting, some complain about their waiting time, and the fact that 
this is affecting their work which gives them earning to enable them pay their treatment cost. 
Aside these, the whole stress of moving up and down and coming to the hospital for like 30days continues 
is worrying to them and this is enough to cause anxiety and eventually depression. 
We therefore tell them to get relief or excuse duty from work or even take some days off while’s treatment 
is ongoing in order to get enough rest to cope with treatment. 
We also advise them to do something they love doing in order to take their minds off all the stress they are 
going through. 
 
Q.3. Feedback from patients  
 
 
Kofi 
Do you get any feedback as responses from patients after these interventions?  
 
Pearl 
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Yes, we do see positive feedback, even from very difficult patients if I should put it that way. There was a 
one patients who came, when she told about the treatment, her response was, she will not do it, and that she 
needed to think about it with her pastor and family. She returned in a month to begin, after thorough 
explanations has been given. 
Eventually, she calm down after a thorough discussion we had with her, because she was somebody who 
was always moody, but after the counselling, she became friendly. She was encouraged to do the treatment 
by the Therapist and that was very positive. 
 
Q.4. Management 
 
Kofi  
In your opinion, what can be done to improve the management of the depression and anxiety of breast 
cancer patients? 
 
Pearl 
I believe we can improve on what we doing, especially from the Therapist point of view. Much more I 
think we need a psychologist who will counsel these patients right from the start of treatment. Apart from 
that, we the Oncology team have do to our best to explain into details to patients on their treatments. Their 
side effects and how to handle them. We also have to encourage to inform the team whatever will be 
bordering them in the course of treatment especially when they go for their reviews.  
 
Q.5. Share your experience 
 
Kofi 
Can you share your experience with me, how you have used your method of interventions described to 
manage the anxiety and depression of patients undergoing treatment. 
 
Pearl 
Well, there are several angles that I can come from with the years of work experience. Some patients come 
in and because at home nobody is minding them, neglected because of the disease, come in with lots of 
complaints. But as you talk to them, you realize that they are in much distress. 
I remember one patient, right from the start, she said she not going to do the treatment because of what she 
had heard, and I had to spend extra time to counsel her. She was afraid she was going to get heart attack 
because somebody told her that her heart is close to the area of treatment. She said so many things and I 
had to sit her down, explain the procedure and side effects of the treatment, though I believe the doctor had 
told her these things. 
I advised her to pray and hope for better. She was better off after the discussions with her.  
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Appendix H: Interview with R2 
Interview with RTT Osei on the 30th June 2017. Osei is a Radiation Therapist at the Oncology Department 
of the Korle-Bu Teaching Hospital. He lives in Accra Ghana and have practiced over Nine years 
 
Q.1. Complaints from Patients 
 
Kofi 
In your daily treatment, do you get complains from patients about their level of depression and anxiety? 
 
Osei 
Oh Yes, severally and sometimes they don’t really need to tell you, looking at them critically will inform 
you that this patients is in some kind of distress and they need some kind of comfort and reassurance. At 
times when they because of the mere fact of the breast cancer disease, you will see that they are depressed, 
even from their responses to the questions you ask them. 
After the explanations of the side effects, patient become even worse and that is where we come in and give 
assurances and reassure of them of the treatment.  
I feel that the informations we give them may be sufficient but the timing is where the problem comes. 
Diagnosis is done in the consulting room, not the treatment room, so I feel when patient at the treatment has 
no informations, then where the informations was given and the timing wasn’t right. The mind is usually 
blogged at the consulting room to the news of the diagnosis. So in this state when counselling is ongoing, 
less information is picked up from. I feel they should be given time to soak this ‘bad news’ if I should put it 
that way, and then a different day is set for counselling for the treatment if the need be.  
 
Q.2. Interventions prescribed 
 
Kofi 
What forms of interventions do you prescribe for these patients?  
 
Osei 
Most of the time, what I personally do is that when they starting the treatment I ask them whether they have 
any idea of the side effects of the treatment and some will boldly say NO. 
Meanwhile, you know that these patients have signed consent and the moment that has been done, patients 
should have idea of the side effects. But, like I said the counseling doesn’t go really well with them because 
of the news of cancer. So patients like these will have to go through counselling again from me. When I see 
that they are still not satisfied with the explanations, I refer them back to the doctor. 
 
Kofi 
Do you think the counseling should be a one-time thing or should be a daily basis? 
 
Osei 
Well, for me I think our weekly review is enough, and meanwhile we the therapist also counsel patients on 
daily basis as they go through their treatment, so I think that is fine. However, a trained counsellor will help 
in this. 
 
Q.3. Feedback from patients  
 
Kofi 
Do you get any feedback as responses from patients after these interventions?  
 
Osei 
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Yes, most of the time I will say its 90% positive. Those who do not put their minds to the reassurances we 
give them of course will have issues. Along the line of treatment, they come back to us and we explain 
further on their questions. Some of the patients by reason of listening to friends and other patients get 
themselves more confused. Because imagine a cervical patients telling a breast patients some of the side 
effects she is experiencing. This breast patient may feel she will experience same side effects. This is where 
some take further burden of depression and anxiety so if they do not come back to tell you their feedback, 
then they go through like this and suffer. 
 
Q.4. Management 
 
Kofi  
In your opinion, what can be done to improve the management of the depression and anxiety of breast 
cancer patients? 
 
Osei 
I think we should get a psychologist or another different doctor to do the counselling, it should not be the 
same doctor who broke the bad news to them. I think that is the only thing we are missing out. 
 
Q.5. Share your experience 
 
Kofi 
Can you share your experience with me, how you have used your method of interventions described to 
manage the anxiety and depression of patients undergoing treatment. 
 
Osei 
Most of the patients have been treated personally, I sometimes give my personal numbers to call in times of 
any distress and have had a good time with some of them. I sometimes even call to verify how they are 
doing, though I will not mention names, I think it’s been cordial with them and the responses have been 
positive. 
There was one patient that did not want to do the treatment but I advised her to go through the treatment 
and that her refusal to undergo treatment may progress the disease and she may get worse. Initially, this 
was difficult but she agreed and went through. Later after her treatment, she came to thank me and was so 
grateful to the team. 
The other patients told me frankly that her pastor advised her not to undergo the treatment. This I also took 
it upon myself to explain to patients, it was not easy from the beginning, but she finally agreed and 
underwent the treatment. She was also grateful to me at the end. 
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Appendix I: Interview with N1 
Interview with Nurse Reginald on the 29th June 2017. Reginald is an Oncology Nurse at the Oncology 
Department of the Korle-Bu Teaching Hospital. He lives in Accra Ghana and have practiced for Six years 
 
Q.1. Complaints from Patients 
 
Kofi 
In your weekly reviews, do you get complains from patients about their level of depression and anxiety? 
 
Reginald 
For depression and anxiety, we’ve got a lot of complain from most if not all the patients undergoing chemo 
radiation. I think the first complain I will mention is the diagnosis of breast cancer in itself. That is a Killer 
if I should put it that way. This alone, will for the rest of the patient life lead to levels of anxiety and 
depression. 
The second thing I will talk about is their financial commitment to the treatment. The chemotherapy drugs 
are very expensive and patients sometimes or most times go through that for six cycles, with a cycle not 
less than GH 1500 or USD 400. This is minus the laboratory investigation before and after each cycle. This 
is just for the chemo, so if you add radiation therapy and surgery, it’s way too expensive for an average 
Ghanaian. Most of the breast cancer patients are low or middle income earners and are predominantly petty 
traders, hence this will be too hard for them to bear resulting in psychological depression and anxiety. 
Others also complain that cancer is a death sentence and that news they hear of friends and other people is 
an indication to this. This in effect increases their anxiety and depression as they are constantly afraid. 
Some of the patients when they undergo adjuvant chemotherapy where chemo is done before surgery, their 
worry always is whether their breast will be cut or not. 
 
Q.2. Interventions prescribed 
 
Kofi 
What forms of interventions do you discuss with these patients?  
 
Reginald 
Our chemo suits has stages, and the first stage is the counselling for the patients and with this we dive 
through and discuss every possible side effect and their related interventions as and when they show up. 
Chemotherapy drugs are very strong and poses several side effect, one of which is the loss of hair. This is 
mind blowing and therefore I take my time to explain to patients and provide possible avenues through this. 
I personally also try to debunk any negative information they have heard from people concerning the 
treatment, like “you will die’, ‘they will cut your breast’, ‘your hair will be gone’ and the likes. Rather, I 
explain the ‘why’ to every patients and the advantages they get if they consent to undergo. 
We also try to inform them of cancer survival groups who have gone through similar treatment and are now 
doing well in life. We also try and introduce the first timers to the chemo suits to allay every anxiety and 
then inform them of the level of competence of the supporting staff group. Aside that we also give 
assistance in the form of introductory letters on request from patients to their work places for financial 
support and the feedback has been positive. Aside these we also provide letters on request for patients to 
churches and other societal organizations for help. Once a while, we do get philanthropist coming through 
to settle some bills for patients.  
All these in one way or the other help patients cope with their anxiety and depression. 
 
Q.3. Feedback from patients  
 
Kofi 
Do you get any feedback as responses from these patients? 
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Reginald 
Oh, we have a positive feedback, for example those with financial burden by their next visit will be smiling 
and cheerful especially when they get support from people. Also, by their next chemo visit, if even they 
may have complaints, they will look more friendly, and open-up, because of the various interventions 
discussed. 
 
Q.4. Management 
 
Kofi  
In your opinion, what can be done to improve the management of the depression and anxiety of breast 
cancer patients? 
 
Reginald 
I think I can only speak from my unit. One thing that I can think of is that you know in most companies or 
hospitals, they have Psychologists and Cognitive behavioral therapist who help in the counselling. So what 
I can say is that if the department can arrange with the hospital in getting at least one of these to be 
stationed in the Centre, it will do a lot of good to our patients. 
Again, the oncology nurse could be sponsored to take extended programs or courses pertaining to psycho-
oncology, so that they can help patients with their level of anxiety and depression. We could also have a 
training session with a trained specialist or a researcher who has done a research into these areas for the 
staff to help them manage patients well. 
 
Q.5. Share your experience 
 
Kofi 
Can you share your experience with me, how you have used your method of interventions described to 
manage the anxiety and depression of patients undergoing treatment. 
 
Reginald 
This is a very good question, what I normally do is that when they come to the chemo suit for the first time, 
I interact with them, because I see that as relieve to patients and then they can open up. I personally talk to 
them about their spirituality because of what I believe. Off course we have variety of patients, some are 
Christians, Muslims, and other traditionalist, but I try to let them know that cancer diagnosis is not a death 
sentence and that is actually not the end of the world. 
What I have seen is that when I start on that level, patients are able to open up to me, talk to me more, they 
feel more relaxed, and that reduces their anxiety and depression level. 
They are so happy, I give them my contacts and chart with them as and when they call me 
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Appendix J: Interview with N2 
Interview with Nurse Enam on the 30th June 2017. Enam is an Oncology Nurse at the Oncology 
Department of the Korle-Bu Teaching Hospital. She lives in Accra Ghana and has practiced for Seven 
years 
 
Q.1. Complaints from Patients 
 
Kofi 
In your clinical reviews, do you get complains from patients about their level of depression and anxiety? 
 
Enam 
Yes, just severally, just recently I have had a patients ask a lot of questions about the chemotherapy, 
apparently she has gone to read about the condition and the management as well as the side effects and was 
worried about a whole lot of things that she feels may happen to him. She expressed concern, anxious and 
doesn’t know how long she will live. The effects of the drugs. I have also come across patients who are so 
depressed of the effects of the chemotherapy on them. According to them, they have lost their hair, their 
finger nails are burnt, and they have several issues with the drug. 
 
Q.2. Interventions prescribed 
 
Kofi 
What forms of advice and interventions do you prescribe for these patients?  
 
Enam 
This was a patient who felt she was not informed about the condition properly by all the doctors that she 
had met and as a result presented to the oncology late. Her stage was advanced and that means her survival 
was small. Upon coming to the Oncology department, she has to go through the treatment but the trauma of 
the whole issue is what is killing plus the fact that she has been told she has few months to live. 
As a Nurse, have tried to talk to this patient lengthy and have spoken the doctors and my superiors about it. 
She is so anxious, though she has not asked anything about death, you can look at her and see so much 
distress. 
 
Q.3. Feedback from patients  
 
Kofi 
Do you get any positive feedback as responses from patients during their next visit of follow-ups?  
 
Enam 
The chemotherapy unit of the department is a small and most times there is very little time you have with 
patients because of the number, space and time. However, the little time we get we do discuss the feedback 
of patients and usually, they complain of several side effects that makes them weaker and more 
apprehensive. 
 
Q.4. Management 
 
Kofi  
In your opinion, what can be done to improve the management of the depression and anxiety of breast 
cancer patients? 
 
Enam 
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There could be a section prior to chemotherapy for counseling where concerns of patients could be 
addressed. There could also be a talk for breast cancer patients at the outpatients department, may be if it is 
even 5minutes prior to their session for the chemotherapy, it can really help. This when done routinely, can 
allay anxiety because the information they read elsewhere, from friends, relatives, family, could affect them 
and make them more depressed and anxious. However, if they hear these from us, they know that well, it is 
from the right source. 
Another thing that could be done, is to get a handout that contains informations on coping with treatment 
and other related issues with breast cancer and share them for these patients. 
I also see pastors in the morning praying with some of the patients and I believe that also help with those 
who believe in these. 
 
Q.5. Share your experience 
 
Kofi 
Can you share your experience with me, how you have used your method of interventions described to 
manage the anxiety and depression of patients undergoing treatment. 
 
Enam 
My experiences with some of the patients have been through counselling, predominantly because I am 
mostly in the chemo suit and usually hear patients and see their mood. As and when I get them I talk to 
them on coping principles and taking care of themselves after treatment. 
 
 
